CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | phenol |
|
Accession: | CHEBI:15882
|
browse the term
|
Definition: | An organic hydroxy compound that consists of benzene bearing a single hydroxy substituent. The parent of the class of phenols. |
Synonyms: | related_synonym: | Benzenol; Carbolsaeure; Formula=C6H6O; Hydroxybenzene; InChI=1S/C6H6O/c7-6-4-2-1-3-5-6/h1-5,7H; InChIKey=ISWSIDIOOBJBQZ-UHFFFAOYSA-N; Karbolsaeure; Oxybenzene; PhOH; Phenic acid; Phenylic acid; Phenylic alcohol; SMILES=Oc1ccccc1; acide carbolique; acide phenique; carbolic acid |
| alt_id: | CHEBI:14777; CHEBI:25966; CHEBI:43543; CHEBI:8071 |
| xref: | Beilstein:969616; CAS:108-95-2; DrugBank:DB03255; Drug_Central:4266; Gmelin:2794; HMDB:HMDB0000228; KEGG:C00146; KEGG:C15584; KEGG:D00033; KEGG:D06536; KNApSAcK:C00002664 |
| xref_mesh: | MESH:D019800 |
| xref: | PDBeChem:IPH; PMID:12058733; PMID:16953321; PMID:17852157; PMID:19029204; PMID:20886261; PMID:21492257; PMID:21689881; PMID:21809019; PMID:21822930; Reaxys:969616; UM-BBD_compID:c0128; Wikipedia:Phenol |
| cyclic_relationship: | is_conjugate_acid_of CHEBI:50526 |
|
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
decreases expression |
ISO |
Phenol results in decreased expression of ACOT2 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 6:103,611,744...103,619,404
Ensembl chr 6:103,611,544...103,619,245
|
|
G |
Afp |
alpha-fetoprotein |
increases expression |
ISO |
Phenol results in increased expression of AFP protein |
CTD |
PMID:16966304 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
Phenol results in increased expression of AKR1B10 mRNA |
CTD |
PMID:26198647 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Alas2 |
5'-aminolevulinate synthase 2 |
multiple interactions |
ISO |
Phenol inhibits the reaction [Hemin results in increased expression of ALAS2 mRNA] |
CTD |
PMID:23973255 |
|
NCBI chr X:19,463,146...19,486,526
Ensembl chr X:19,463,171...19,486,519
|
|
G |
Alb |
albumin |
affects binding |
ISO |
Phenol binds to ALB protein |
CTD |
PMID:11334365 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases expression |
ISO |
Phenol results in increased expression of ALPL mRNA |
CTD |
PMID:22083529 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
increases expression |
ISO |
Phenol results in increased expression of BAMBI mRNA |
CTD |
PMID:17547211 |
|
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
increases expression |
ISO |
Phenol results in increased expression of BHLHE40 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
|
|
G |
Blcap |
BLCAP, apoptosis inducing factor |
decreases expression |
ISO |
Phenol results in decreased expression of BLCAP mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 3:146,222,699...146,232,859
Ensembl chr 3:146,222,240...146,232,909
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
multiple interactions decreases expression |
EXP |
Capsaicin promotes the reaction [Phenol results in decreased expression of CALCA protein] Phenol results in decreased expression of CALCA mRNA; Phenol results in decreased expression of CALCA protein |
CTD |
PMID:15120475 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Calcb |
calcitonin-related polypeptide, beta |
decreases expression |
EXP |
Phenol results in decreased expression of CALCB mRNA |
CTD |
PMID:15120475 |
|
NCBI chr 1:168,966,465...168,970,125
Ensembl chr 1:168,966,465...168,970,125
|
|
G |
Calu |
calumenin |
decreases expression |
ISO |
Phenol results in decreased expression of CALU mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
|
|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
Phenol results in increased activity of CASP3 protein |
CTD |
PMID:23776099 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
Phenol results in increased activity of CASP8 protein |
CTD |
PMID:23776099 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
Phenol results in increased activity of CASP9 protein |
CTD |
PMID:23776099 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
Phenol results in increased expression of CCL2 mRNA |
CTD |
PMID:21907259 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
Phenol results in decreased expression of CCNA2 protein |
CTD |
PMID:19293009 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Chst3 |
carbohydrate sulfotransferase 3 |
increases expression |
ISO |
Phenol results in increased expression of CHST3 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr20:28,114,387...28,152,046
Ensembl chr20:28,114,404...28,121,807
|
|
G |
Cldn1 |
claudin 1 |
affects localization |
ISO |
Phenol affects the localization of CLDN1 protein |
CTD |
PMID:19679145 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
increases expression |
ISO |
Phenol results in increased expression of COL1A1 mRNA |
CTD |
PMID:22083529 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
increases expression |
ISO |
Phenol results in increased expression of CREB1 mRNA |
CTD |
PMID:20385217 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
increases expression |
EXP |
Phenol results in increased expression of CYBA mRNA |
CTD |
PMID:16785328 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cybb |
cytochrome b-245 beta chain |
increases expression |
EXP |
Phenol results in increased expression of CYBB mRNA |
CTD |
PMID:16785328 |
|
NCBI chr X:13,360,583...13,392,517
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
affects response to substance |
ISO |
CYP1A1 protein affects the susceptibility to Phenol |
CTD |
PMID:8242868 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
affects response to substance |
ISO |
CYP1A2 protein affects the susceptibility to Phenol |
CTD |
PMID:8242868 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
multiple interactions |
EXP |
[CYP2B1 protein results in increased metabolism of Benzene] which results in increased chemical synthesis of Phenol |
CTD |
PMID:8211999 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases metabolic processing multiple interactions |
ISO EXP |
CYP2E1 protein results in increased metabolism of Phenol [CYP2E1 protein results in increased metabolism of Benzene] which results in increased chemical synthesis of Phenol; [CYP2E1 protein results in increased metabolism of Phenol] which results in increased chemical synthesis of catechol; [CYP2E1 protein results in increased metabolism of Phenol] which results in increased chemical synthesis of hydroquinone; [Glutathione co-treated with [CYP2E1 protein results in increased metabolism of Phenol]] results in increased chemical synthesis of [Glutathione binds to hydroquinone metabolite]; EPHX1 protein promotes the reaction [[CYP2E1 protein results in increased metabolism of Benzene] which results in increased chemical synthesis of Phenol]; EPHX1 protein promotes the reaction [[CYP2E1 protein results in increased metabolism of Phenol] which results in increased chemical synthesis of catechol]; EPHX1 protein promotes the reaction [[CYP2E1 protein results in increased metabolism of Phenol] which results in increased chemical synthesis of hydroquinone]; EPHX1 protein promotes the reaction [CYP2E1 protein results in increased metabolism of Phenol] [CYP2E1 protein affects the metabolism of Benzene] which affects the chemical synthesis of Phenol |
CTD |
PMID:8211999 PMID:11701230 PMID:15051535 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
increases metabolic processing |
ISO |
CYP2F2 protein results in increased metabolism of Phenol |
CTD |
PMID:11701230 |
|
NCBI chr 1:82,416,108...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Cyp4f18 |
cytochrome P450, family 4, subfamily f, polypeptide 18 |
increases expression |
ISO |
Phenol results in increased expression of CYP4F3 mRNA; Phenol results in increased expression of CYP4F3 protein |
CTD |
PMID:19029204 PMID:20036648 |
|
NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,707,317...17,804,940
|
|
G |
Dazap1 |
DAZ associated protein 1 |
increases expression |
ISO |
Phenol results in increased expression of DAZAP1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 7:9,423,673...9,448,116
Ensembl chr 7:9,424,178...9,538,818
|
|
G |
Dcp1a |
decapping mRNA 1A |
increases expression |
ISO |
Phenol results in increased expression of DCP1A mRNA |
CTD |
PMID:17547211 |
|
NCBI chr16:5,656,788...5,702,151
Ensembl chr16:5,656,773...5,702,140
|
|
G |
Ddx3x |
DEAD-box helicase 3, X-linked |
decreases expression |
ISO |
Phenol results in decreased expression of DDX3X mRNA |
CTD |
PMID:17547211 |
|
NCBI chr X:9,479,532...9,493,455
Ensembl chr X:9,479,532...9,493,168
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
Phenol results in increased expression of DUSP1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr10:16,680,489...16,683,276
|
|
G |
Ell2 |
elongation factor for RNA polymerase II 2 |
increases expression |
ISO |
Phenol results in increased expression of ELL2 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 2:5,189,375...5,258,781
Ensembl chr 2:5,189,971...5,258,781
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
multiple interactions |
EXP |
EPHX1 protein promotes the reaction [[CYP2E1 protein results in increased metabolism of Benzene] which results in increased chemical synthesis of Phenol]; EPHX1 protein promotes the reaction [[CYP2E1 protein results in increased metabolism of Phenol] which results in increased chemical synthesis of catechol]; EPHX1 protein promotes the reaction [[CYP2E1 protein results in increased metabolism of Phenol] which results in increased chemical synthesis of hydroquinone]; EPHX1 protein promotes the reaction [CYP2E1 protein results in increased metabolism of Phenol] |
CTD |
PMID:8211999 |
|
NCBI chr13:92,714,315...92,744,124
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Esr1 |
estrogen receptor 1 |
increases expression |
ISO |
Phenol results in increased expression of ESR1 mRNA |
CTD |
PMID:22083529 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
increases expression |
ISO |
Phenol results in increased expression of ETS2 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
Phenol results in increased expression of FAS mRNA; Phenol results in increased expression of FAS protein |
CTD |
PMID:17547211 PMID:23776099 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
increases expression |
ISO |
Phenol results in increased expression of FASLG protein |
CTD |
PMID:23776099 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fbxw2 |
F-box and WD repeat domain containing 2 |
decreases expression |
ISO |
Phenol results in decreased expression of FBXW2 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 3:18,088,859...18,114,387
Ensembl chr 3:18,088,865...18,114,381
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
increases expression |
ISO |
Phenol results in increased expression of FOSL1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Gata1 |
GATA binding protein 1 |
multiple interactions |
ISO |
decitabine inhibits the reaction [Phenol inhibits the reaction [Hemin results in increased expression of GATA1 mRNA]]; Phenol inhibits the reaction [Hemin results in increased expression of GATA1 mRNA] |
CTD |
PMID:21414390 PMID:23973255 |
|
NCBI chr X:14,529,706...14,537,530
Ensembl chr X:14,529,702...14,537,530
|
|
G |
Gata2 |
GATA binding protein 2 |
multiple interactions decreases expression |
ISO |
Phenol promotes the reaction [Hemin results in decreased expression of GATA2 mRNA] Phenol results in decreased expression of GATA2 mRNA |
CTD |
PMID:21414390 |
|
NCBI chr 4:120,654,205...120,667,763
Ensembl chr 4:120,658,986...120,667,761
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
ISO |
Phenol results in increased expression of GCLC mRNA |
CTD |
PMID:26198647 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
Phenol results in increased expression of GCLM mRNA |
CTD |
PMID:26198647 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
increases expression |
EXP |
Phenol results in increased expression of GJA1 mRNA; Phenol results in increased expression of GJA1 protein |
CTD |
PMID:15094358 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gpat3 |
glycerol-3-phosphate acyltransferase 3 |
increases expression |
ISO |
Phenol results in increased expression of GPAT3 mRNA |
CTD |
PMID:26198647 |
|
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
|
|
G |
Gtf3c4 |
general transcription factor IIIC subunit 4 |
increases expression |
ISO |
Phenol results in increased expression of GTF3C4 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 3:12,154,803...12,172,795
Ensembl chr 3:12,154,805...12,172,725
|
|
G |
H2ax |
H2A.X variant histone |
affects localization |
ISO |
Phenol affects the localization of H2AX protein modified form |
CTD |
PMID:20096274 |
|
NCBI chr 8:44,671,927...44,673,257
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
increases expression |
ISO |
Phenol results in increased expression of HAVCR1 mRNA |
CTD |
PMID:21907259 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hbb |
hemoglobin subunit beta |
multiple interactions increases methylation |
ISO |
decitabine inhibits the reaction [Phenol inhibits the reaction [Hemin results in increased expression of HBB mRNA]]; Phenol inhibits the reaction [Hemin results in increased expression of HBB mRNA] Phenol results in increased methylation of HBB promoter |
CTD |
PMID:21414390 PMID:23973255 |
|
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
increases expression |
ISO |
Phenol results in increased expression of HES1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hmbs |
hydroxymethylbilane synthase |
multiple interactions increases methylation |
ISO |
decitabine inhibits the reaction [Phenol inhibits the reaction [Hemin results in increased expression of HMBS mRNA]]; Phenol inhibits the reaction [Hemin results in increased expression of HMBS mRNA] Phenol results in increased methylation of HMBS gene |
CTD |
PMID:21414390 PMID:23973255 |
|
NCBI chr 8:44,673,554...44,680,950
Ensembl chr 8:44,673,554...44,680,957
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
Phenol results in increased expression of HMOX1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnrnph2 |
heterogeneous nuclear ribonucleoprotein H2 |
decreases expression |
ISO |
Phenol results in decreased expression of HNRNPH2 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr X:97,780,890...97,786,846
Ensembl chr X:97,780,785...97,787,041
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
increases expression |
ISO |
Phenol results in increased expression of ID3 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Il1a |
interleukin 1 alpha |
increases secretion increases expression multiple interactions |
ISO |
Phenol results in increased secretion of IL1A protein Phenol results in increased expression of IL1A mRNA; Phenol results in increased expression of IL1A protein IL1A protein affects the reaction [Phenol results in increased expression of CXCL8 protein] |
CTD |
PMID:8006454 PMID:16522979 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression decreases expression increases secretion |
ISO EXP |
Glutathione deficiency promotes the reaction [Phenol results in increased secretion of IL1B protein] Phenol results in increased expression of IL1B mRNA Phenol results in decreased expression of IL1B tempol inhibits the reaction [Phenol results in decreased expression of IL1B mRNA] |
CTD |
PMID:8006454 PMID:12160195 PMID:16785328 PMID:17922553 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
decreases expression |
ISO |
Phenol results in decreased expression of IL6 mRNA |
CTD |
PMID:12819374 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ing3 |
inhibitor of growth family, member 3 |
increases expression |
ISO |
Phenol results in increased expression of ING3 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 4:50,477,954...50,505,168
Ensembl chr 4:50,477,962...50,503,715
|
|
G |
Klf10 |
KLF transcription factor 10 |
increases expression |
ISO |
Phenol results in increased expression of KLF10 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 7:69,467,658...69,473,726
Ensembl chr 7:69,465,619...69,473,994
|
|
G |
Klf6 |
KLF transcription factor 6 |
increases expression |
ISO |
Phenol results in increased expression of KLF6 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
|
|
G |
Kpna4 |
karyopherin subunit alpha 4 |
increases expression |
ISO |
Phenol results in increased expression of KPNA4 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 2:153,319,380...153,381,085
Ensembl chr 2:153,324,273...153,381,081
|
|
G |
Lrp5 |
LDL receptor related protein 5 |
increases expression |
ISO |
Phenol results in increased expression of LRP5 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 1:200,814,247...200,917,581
Ensembl chr 1:200,814,250...200,917,581
|
|
G |
Luc7l3 |
LUC7-like 3 pre-mRNA splicing factor |
decreases expression |
ISO |
Phenol results in decreased expression of CROP mRNA |
CTD |
PMID:17547211 |
|
NCBI chr10:79,240,050...79,276,555
Ensembl chr10:79,240,563...79,276,538
|
|
G |
Man1a2 |
mannosidase, alpha, class 1A, member 2 |
decreases expression |
ISO |
Phenol results in decreased expression of MAN1A2 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 2:187,947,484...188,096,332
Ensembl chr 2:187,951,617...188,096,332
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
decreases expression |
ISO |
Phenol results in decreased expression of MCL1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Mgat2 |
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase |
decreases expression |
ISO |
Phenol results in decreased expression of MGAT2 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 6:87,656,360...87,658,849
Ensembl chr 6:87,656,349...87,658,177
|
|
G |
Mir126a |
microRNA 126a |
increases expression |
ISO |
Phenol results in increased expression of MIR126A mRNA |
CTD |
PMID:32105654 |
|
NCBI chr 3:9,415,063...9,415,180
Ensembl chr 3:9,415,063...9,415,180
|
|
G |
Mir129-1 |
microRNA 129-1 |
decreases expression |
ISO |
Phenol results in decreased expression of MIR129-1 mRNA |
CTD |
PMID:32105654 |
|
NCBI chr 4:57,624,295...57,624,366
Ensembl chr 4:57,624,295...57,624,366
|
|
G |
Mir134 |
microRNA 134 |
decreases expression |
ISO |
Phenol results in decreased expression of MIR134 mRNA |
CTD |
PMID:32105654 |
|
NCBI chr 6:128,748,908...128,748,980
|
|
G |
Mir135b |
microRNA 135b |
decreases expression |
ISO |
Phenol results in decreased expression of MIR135B mRNA |
CTD |
PMID:32105654 |
|
NCBI chr13:43,638,857...43,638,953
Ensembl chr13:43,638,857...43,638,953
|
|
G |
Mir145 |
microRNA 145 |
decreases expression |
ISO |
Phenol results in decreased expression of MIR145A mRNA |
CTD |
PMID:32105654 |
|
NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
|
|
G |
Mir150 |
microRNA 150 |
increases expression |
ISO |
Phenol results in increased expression of MIR150 mRNA |
CTD |
PMID:32105654 |
|
NCBI chr 1:95,605,024...95,605,108
Ensembl chr 1:95,605,024...95,605,108
|
|
G |
Mir16 |
microRNA 16 |
decreases expression |
ISO |
Phenol results in decreased expression of MIR16-2 mRNA |
CTD |
PMID:32105654 |
|
NCBI chr 2:153,245,349...153,245,443
Ensembl chr 2:153,245,349...153,245,443
|
|
G |
Mir1912 |
microRNA 1912 |
increases expression |
ISO |
Phenol results in increased expression of MIR1912 mRNA |
CTD |
PMID:32105654 |
|
NCBI chr X:110,685,978...110,686,065
Ensembl chr X:110,685,978...110,686,065
|
|
G |
Mir193b |
microRNA 193b |
decreases expression |
ISO |
Phenol results in decreased expression of MIR193B mRNA |
CTD |
PMID:32105654 |
|
NCBI chr10:1,317,742...1,317,824
Ensembl chr10:1,317,742...1,317,824
|
|
G |
Mir196c |
microRNA 196c |
decreases expression |
ISO |
Phenol results in decreased expression of MIR196A-1 mRNA |
CTD |
PMID:32105654 |
|
NCBI chr10:81,231,006...81,231,085
Ensembl chr10:81,231,006...81,231,085
|
|
G |
Mir200b |
microRNA 200b |
decreases expression |
ISO |
Phenol results in decreased expression of MIR200B mRNA |
CTD |
PMID:32105654 |
|
NCBI chr 5:166,649,272...166,649,366
Ensembl chr 5:166,649,272...166,649,366
|
|
G |
Mir204 |
microRNA 204 |
increases expression |
ISO |
Phenol results in increased expression of MIR204 mRNA |
CTD |
PMID:32105654 |
|
NCBI chr 1:220,316,931...220,317,040
Ensembl chr 1:220,316,931...220,317,040
|
|
G |
Mir212 |
microRNA 212 |
decreases expression |
ISO |
Phenol results in decreased expression of MIR212 mRNA |
CTD |
PMID:32105654 |
|
NCBI chr10:60,023,403...60,023,513
Ensembl chr10:60,023,403...60,023,513
|
|
G |
Mir214 |
microRNA 214 |
increases expression |
ISO |
Phenol results in increased expression of MIR214 mRNA |
CTD |
PMID:32105654 |
|
NCBI chr13:74,588,374...74,588,481
Ensembl chr13:74,588,372...74,588,481
|
|
G |
Mir224 |
microRNA 224 |
decreases expression |
ISO |
Phenol results in decreased expression of MIR224 mRNA |
CTD |
PMID:32105654 |
|
NCBI chr X:150,065,088...150,065,169
Ensembl chr X:150,065,088...150,065,169
|
|
G |
Mir34b |
microRNA 34b |
decreases expression |
ISO |
Phenol results in decreased expression of MIR34B mRNA |
CTD |
PMID:32105654 |
|
NCBI chr 8:51,410,244...51,410,327
Ensembl chr 8:51,410,244...51,410,327
|
|
G |
Mir383 |
microRNA 383 |
increases expression |
ISO |
Phenol results in increased expression of MIR383 mRNA |
CTD |
PMID:32105654 |
|
NCBI chr16:54,040,340...54,040,413
Ensembl chr16:54,040,340...54,040,413
|
|
G |
Mir410 |
microRNA 410 |
increases expression |
ISO |
Phenol results in increased expression of MIR410 mRNA |
CTD |
PMID:32105654 |
|
NCBI chr 6:128,758,358...128,758,433
Ensembl chr 6:128,758,354...128,758,434
|
|
G |
Mir488 |
microRNA 488 |
increases expression |
ISO |
Phenol results in increased expression of MIR488 mRNA |
CTD |
PMID:32105654 |
|
NCBI chr13:70,683,064...70,683,142
Ensembl chr13:70,683,064...70,683,142
|
|
G |
Mir542 |
microRNA 542 |
decreases expression |
ISO |
Phenol results in decreased expression of MIR542 mRNA |
CTD |
PMID:32105654 |
|
NCBI chr X:132,802,623...132,802,701
Ensembl chr X:132,802,623...132,802,701
|
|
G |
Mir877 |
microRNA 877 |
increases expression |
ISO |
Phenol results in increased expression of MIR877 mRNA |
CTD |
PMID:32105654 |
|
NCBI chr20:2,811,476...2,811,560
Ensembl chr20:2,811,476...2,811,560
|
|
G |
Mir96 |
microRNA 96 |
decreases expression |
ISO |
Phenol results in decreased expression of MIR96 mRNA |
CTD |
PMID:32105654 |
|
NCBI chr 4:58,788,411...58,788,516
Ensembl chr 4:58,788,411...58,788,516
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions increases hydroxylation |
ISO |
[MPO protein results in increased hydroxylation of Phenol] which results in increased chemical synthesis of hydroquinone |
CTD |
PMID:1666626 |
|
NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mrpl49 |
mitochondrial ribosomal protein L49 |
decreases expression |
ISO |
Phenol results in decreased expression of MRPL49 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 1:203,346,068...203,350,040
Ensembl chr 1:203,332,481...203,350,049
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression |
ISO |
Phenol results in increased expression of MYC mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
increases expression |
EXP |
Phenol results in increased expression of NCF1 mRNA |
CTD |
PMID:16785328 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Nfe2 |
nuclear factor, erythroid 2 |
multiple interactions |
ISO |
Phenol inhibits the reaction [Hemin results in increased expression of NFE2 mRNA] |
CTD |
PMID:21414390 |
|
NCBI chr 7:134,382,758...134,395,364
Ensembl chr 7:134,382,761...134,390,108
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
increases expression |
ISO |
Phenol results in increased expression of NFKB1 mRNA |
CTD |
PMID:20385217 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfya |
nuclear transcription factor Y subunit alpha |
increases expression |
ISO |
Phenol results in increased expression of NFYA mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 9:12,587,437...12,613,911
Ensembl chr 9:12,586,259...12,613,898
|
|
G |
Nos1 |
nitric oxide synthase 1 |
multiple interactions decreases expression |
EXP |
tempol inhibits the reaction [Phenol results in decreased expression of NOS1 mRNA] |
CTD |
PMID:12160195 PMID:16785328 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nox3 |
NADPH oxidase 3 |
increases expression |
EXP |
Phenol results in increased expression of NOX3 mRNA |
CTD |
PMID:16785328 |
|
NCBI chr 1:44,238,012...44,302,851
Ensembl chr 1:44,236,992...44,302,851
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity increases expression |
ISO |
Phenol results in increased activity of NQO1 protein Phenol results in increased expression of NQO1 mRNA |
CTD |
PMID:9029048 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
decreases expression |
ISO |
Phenol results in decreased expression of NR0B2 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Peli1 |
pellino E3 ubiquitin protein ligase 1 |
increases expression |
ISO |
Phenol results in increased expression of PELI1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr14:95,254,274...95,309,168
Ensembl chr14:95,254,589...95,308,285
|
|
G |
Per2 |
period circadian regulator 2 |
increases expression |
ISO |
Phenol results in increased expression of PER2 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 9:92,007,289...92,049,551
Ensembl chr 9:92,007,296...92,049,459
|
|
G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
increases expression |
ISO |
Phenol results in increased expression of PIK3CD mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 5:160,094,952...160,142,962
Ensembl chr 5:160,094,952...160,120,930
|
|
G |
Pim1 |
Pim-1 proto-oncogene, serine/threonine kinase |
increases expression |
ISO |
Phenol results in increased expression of PIM1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,554,921...7,559,174
|
|
G |
Pnma1 |
PNMA family member 1 |
decreases expression |
ISO |
Phenol results in decreased expression of PNMA1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 6:103,782,244...103,784,029
Ensembl chr 6:103,773,889...103,784,567
|
|
G |
Pnn |
pinin, desmosome associated protein |
decreases expression |
ISO |
Phenol results in decreased expression of PNN mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 6:76,758,138...76,766,451
Ensembl chr 6:76,758,117...76,766,889
|
|
G |
Pnpla6 |
patatin-like phospholipase domain containing 6 |
multiple interactions |
ISO |
[PNPLA6 protein results in increased hydrolysis of phenyl valerate] which results in increased chemical synthesis of Phenol |
CTD |
PMID:20603202 |
|
NCBI chr12:1,574,387...1,603,735
Ensembl chr12:1,560,363...1,603,734
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression |
ISO |
Phenol results in increased expression of PPARG mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppm1d |
protein phosphatase, Mg2+/Mn2+ dependent, 1D |
increases expression |
ISO |
Phenol results in increased expression of PPM1D mRNA |
CTD |
PMID:17547211 |
|
NCBI chr10:70,172,603...70,208,607
Ensembl chr10:70,172,603...70,208,607
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
increases expression affects localization |
ISO |
Phenol results in increased expression of PRKDC; Phenol results in increased expression of PRKDC mRNA; Phenol results in increased expression of PRKDC protein Phenol affects the localization of PRKDC protein |
CTD |
PMID:20036648 PMID:20096274 |
|
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
|
|
G |
Rab9a |
RAB9A, member RAS oncogene family |
decreases expression |
ISO |
Phenol results in decreased expression of RAB9A mRNA |
CTD |
PMID:17547211 |
|
NCBI chr X:27,955,552...28,009,870
Ensembl chr X:27,952,204...28,001,622
|
|
G |
Repin1 |
replication initiator 1 |
decreases expression |
ISO |
Phenol results in decreased expression of REPIN1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 4:77,548,722...77,554,242
Ensembl chr 4:77,548,849...77,554,257
|
|
G |
Rraga |
Ras-related GTP binding A |
decreases expression |
ISO |
Phenol results in decreased expression of RRAGA mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 5:101,113,341...101,114,936
Ensembl chr 5:101,112,859...101,114,510
|
|
G |
Scand1 |
SCAN domain-containing 1 |
decreases expression |
ISO |
Phenol results in decreased expression of SCAND1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 3:144,818,615...144,819,479
Ensembl chr 3:144,818,611...144,820,025
|
|
G |
Scarna15 |
small Cajal body-specific RNA 15 |
decreases expression |
ISO |
Phenol results in decreased expression of MIR1839 mRNA |
CTD |
PMID:32105654 |
|
NCBI chr 1:135,484,620...135,484,683
Ensembl chr 1:135,484,559...135,484,685
|
|
G |
Sephs2 |
selenophosphate synthetase 2 |
decreases expression |
ISO |
Phenol results in decreased expression of SEPHS2 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 1:181,893,146...181,895,464
Ensembl chr 1:181,892,599...181,895,497
|
|
G |
Sik1 |
salt-inducible kinase 1 |
increases expression |
ISO |
Phenol results in increased expression of SIK1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr20:9,949,407...9,959,036
Ensembl chr20:9,947,396...9,958,991
|
|
G |
Sirt1 |
sirtuin 1 |
increases expression |
ISO |
Phenol results in increased expression of SIRT1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr20:25,307,143...25,329,260
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc12a6 |
solute carrier family 12, member 6 |
increases expression |
ISO |
Phenol results in increased expression of SLC12A6 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 3:99,071,577...99,170,266
Ensembl chr 3:99,071,391...99,170,258
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression |
ISO |
Phenol results in increased expression of SLC7A11 mRNA |
CTD |
PMID:26198647 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression |
ISO |
Phenol results in increased expression of SQSTM1 mRNA |
CTD |
PMID:26198647 |
|
NCBI chr10:34,525,517...34,536,685
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srsf1 |
serine and arginine rich splicing factor 1 |
decreases expression |
ISO |
Phenol results in decreased expression of SRSF1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr10:72,838,926...72,859,066
Ensembl chr10:72,839,274...72,845,336
|
|
G |
Srsf5 |
serine and arginine rich splicing factor 5 |
decreases expression |
ISO |
Phenol results in decreased expression of SRSF5 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 6:100,605,165...100,610,192
Ensembl chr 6:100,605,456...100,610,177
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression |
ISO |
Phenol results in increased expression of SRXN1 mRNA |
CTD |
PMID:26198647 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Ss18l2 |
SS18 like 2 |
decreases expression |
ISO |
Phenol results in decreased expression of SS18L2 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 8:121,375,249...121,377,877
Ensembl chr 8:121,375,308...121,377,877
|
|
G |
Taf7 |
TATA-box binding protein associated factor 7 |
decreases expression |
ISO |
Phenol results in decreased expression of TAF7 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr18:29,459,937...29,462,086
Ensembl chr18:29,452,943...29,462,134
|
|
G |
Tardbp |
TAR DNA binding protein |
decreases expression |
ISO |
Phenol results in decreased expression of TARDBP mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 5:159,050,518...159,062,218
Ensembl chr 5:159,051,799...159,062,055
|
|
G |
Tcfl5 |
transcription factor like 5 |
increases expression |
ISO |
Phenol results in increased expression of TCFL5 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 3:167,734,471...167,754,174
Ensembl chr 3:167,734,473...167,754,282
|
|
G |
Terf2 |
telomeric repeat binding factor 2 |
increases expression |
ISO |
Phenol results in increased expression of TERF2 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr19:34,976,963...35,005,813
Ensembl chr19:34,977,471...35,005,819
|
|
G |
Tfrc |
transferrin receptor |
decreases expression multiple interactions |
ISO |
Phenol results in decreased expression of TFRC protein Phenol promotes the reaction [Hemin results in decreased expression of TFRC mRNA] |
CTD |
PMID:21414390 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tgif1 |
TGFB-induced factor homeobox 1 |
increases expression |
ISO |
Phenol results in increased expression of TGIF1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 9:110,748,094...110,757,714
Ensembl chr 9:110,720,921...110,757,802
|
|
G |
Timm17a |
translocase of inner mitochondrial membrane 17A |
decreases expression |
ISO |
Phenol results in decreased expression of TIMM17A mRNA |
CTD |
PMID:17547211 |
|
NCBI chr13:46,731,117...46,742,604
Ensembl chr13:46,730,660...46,742,655
|
|
G |
Tjp1 |
tight junction protein 1 |
affects localization |
ISO |
Phenol affects the localization of TJP1 protein |
CTD |
PMID:19679145 |
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression multiple interactions increases expression increases secretion |
ISO |
Phenol results in decreased expression of TNF mRNA TNF protein affects the reaction [Phenol results in increased expression of CXCL8 protein] Phenol results in increased expression of TNF mRNA; Phenol results in increased expression of TNF protein Phenol results in increased secretion of TNF protein |
CTD |
PMID:8006454 PMID:12819374 PMID:16522979 PMID:20385217 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
increases expression |
ISO |
Phenol results in increased expression of TNFAIP3 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tnfrsf21 |
TNF receptor superfamily member 21 |
increases expression |
ISO |
Phenol results in increased expression of TNFRSF21 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 9:17,879,156...17,954,085
Ensembl chr 9:17,879,156...17,954,085
|
|
G |
Tob1 |
transducer of ErbB-2.1 |
decreases expression |
ISO |
Phenol results in decreased expression of TOB1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr10:79,163,093...79,165,131
Ensembl chr10:79,160,154...79,165,215
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
ISO |
Phenol results in increased expression of TRP53 protein |
CTD |
PMID:9667752 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trib1 |
tribbles pseudokinase 1 |
increases expression |
ISO |
Phenol results in increased expression of TRIB1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 7:91,206,579...91,213,126
Ensembl chr 7:91,206,579...91,214,731
|
|
G |
Tuft1 |
tuftelin 1 |
increases expression |
ISO |
Phenol results in increased expression of TUFT1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 2:182,259,457...182,306,296
Ensembl chr 2:182,260,398...182,306,192
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases expression |
ISO |
Phenol results in increased expression of TXNRD1 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Ugcg |
UDP-glucose ceramide glucosyltransferase |
increases expression |
ISO |
Phenol results in increased expression of UGCG mRNA |
CTD |
PMID:17547211 |
|
NCBI chr 5:74,032,978...74,065,701
Ensembl chr 5:74,032,978...74,065,393
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
increases metabolic processing |
EXP |
UGT1A6 protein results in increased metabolism of Phenol |
CTD |
PMID:9118891 |
|
NCBI chr 9:88,747,229...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Vnn1 |
vanin 1 |
increases expression |
ISO |
Phenol results in increased expression of VNN1 mRNA |
CTD |
PMID:21907259 |
|
NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
|
|
G |
Vrk2 |
VRK serine/threonine kinase 2 |
increases expression |
ISO |
Phenol results in increased expression of VRK2 mRNA |
CTD |
PMID:17547211 |
|
NCBI chr14:100,313,771...100,434,605
Ensembl chr14:100,313,601...100,434,527
|
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[CYP1A2 protein results in increased metabolism of coumarin] which results in increased abundance of 2-hydroxyphenylacetic acid |
CTD |
PMID:34334558 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
ISO |
[CYP2E1 protein results in increased metabolism of coumarin] which results in increased abundance of 2-hydroxyphenylacetic acid |
CTD |
PMID:34334558 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
multiple interactions increases expression |
ISO |
[Butylated Hydroxytoluene co-treated with iron(II)-ascorbic acid complex] results in increased expression of ABCA1 protein; Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of ABCA1 mRNA]; Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of ABCA1 protein] Butylated Hydroxytoluene results in increased expression of ABCA1 mRNA |
CTD |
PMID:17070507 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] |
CTD |
PMID:16757516 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actg1 |
actin, gamma 1 |
increases expression |
EXP |
Butylated Hydroxytoluene results in increased expression of ACTG1 mRNA |
CTD |
PMID:12082028 |
|
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [AGT protein results in increased expression of PSMC6 protein]; Butylated Hydroxytoluene inhibits the reaction [AGT protein results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:17532611 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Aifm2 |
apoptosis inducing factor, mitochondria associated 2 |
multiple interactions |
EXP |
Butylated Hydroxytoluene inhibits the reaction [ganglioside, GD3 results in increased secretion of AIFM2 protein]; Butylated Hydroxytoluene inhibits the reaction [Hydrogen Peroxide results in increased secretion of AIFM2 protein] |
CTD |
PMID:14987999 |
|
NCBI chr20:29,654,283...29,679,239
Ensembl chr20:29,652,927...29,679,236
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
increases expression increases activity |
EXP |
Butylated Hydroxytoluene results in increased expression of AKR7A3 protein Butylated Hydroxytoluene results in increased activity of AKR7A3 protein |
CTD |
PMID:8198522 PMID:9328168 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases phosphorylation |
EXP |
Butylated Hydroxytoluene results in increased phosphorylation of AKT1 protein |
CTD |
PMID:17604070 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
affects localization multiple interactions |
ISO |
Butylated Hydroxytoluene affects the localization of ALOX5 protein celecoxib inhibits the reaction [Butylated Hydroxytoluene affects the localization of ALOX5 protein] |
CTD |
PMID:12376474 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Apoa1 |
apolipoprotein A1 |
multiple interactions |
ISO |
[Butylated Hydroxytoluene co-treated with Pentetic Acid] inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein]; Butylated Hydroxytoluene inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein] |
CTD |
PMID:12576517 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apoa2 |
apolipoprotein A2 |
multiple interactions |
ISO |
[Butylated Hydroxytoluene co-treated with Pentetic Acid] inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA2 protein]; Butylated Hydroxytoluene inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA2 protein] |
CTD |
PMID:12576517 |
|
NCBI chr13:83,644,460...83,646,358
Ensembl chr13:83,644,470...83,646,355
|
|
G |
Apoa4 |
apolipoprotein A4 |
increases expression |
EXP |
Butylated Hydroxytoluene results in increased expression of APOA4 mRNA |
CTD |
PMID:12082028 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein] |
CTD |
PMID:10696776 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arg1 |
arginase 1 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of ARG1 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Atp2a1 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
multiple interactions |
EXP |
Butylated Hydroxytoluene inhibits the reaction [[ferrous sulfate co-treated with Edetic Acid] results in decreased activity of ATP2A1 protein]; Butylated Hydroxytoluene inhibits the reaction [Free Radicals results in decreased activity of ATP2A1 protein] |
CTD |
PMID:12870653 |
|
NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838
|
|
G |
Atp6v1a |
ATPase H+ transporting V1 subunit A |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Reactive Oxygen Species results in decreased expression of ATP6V1A protein] Butylated Hydroxytoluene inhibits the reaction [TNF protein results in decreased expression of ATP6V1A protein] |
CTD |
PMID:12470298 |
|
NCBI chr11:56,561,444...56,614,694
Ensembl chr11:56,560,974...56,614,694
|
|
G |
C5 |
complement C5 |
increases expression |
EXP |
Butylated Hydroxytoluene results in increased expression of HC mRNA |
CTD |
PMID:12082028 |
|
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
Capn2 |
calpain 2 |
affects expression |
ISO |
Butylated Hydroxytoluene affects the expression of CAPN2 protein |
CTD |
PMID:7716780 |
|
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
|
|
G |
Caprin1 |
cell cycle associated protein 1 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of CAPRIN1 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 3:90,152,305...90,230,447
Ensembl chr 3:90,153,620...90,230,502
|
|
G |
Car2 |
carbonic anhydrase 2 |
decreases activity |
ISO |
Butylated Hydroxytoluene results in decreased activity of CA2 protein |
CTD |
PMID:19231207 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Casp3 |
caspase 3 |
multiple interactions decreases activity |
ISO EXP |
[Butylated Hydroxyanisole co-treated with Butylated Hydroxytoluene] results in decreased activity of CASP3 protein Butylated Hydroxytoluene inhibits the reaction [ganglioside, GD3 results in increased cleavage of and results in increased activity of CASP3 protein]; Butylated Hydroxytoluene inhibits the reaction [Lithium Carbonate results in increased activity of CASP3 protein] [Butylated Hydroxytoluene co-treated with Oxygen] results in increased cleavage of CASP3 protein; zAsp(Ome)-Arg-His-Asp(Ome)-fluoromethyl ketone inhibits the reaction [[Butylated Hydroxytoluene co-treated with Oxygen] results in increased cleavage of CASP3 protein] Butylated Hydroxytoluene results in decreased activity of CASP3 protein |
CTD |
PMID:10783138 PMID:14981915 PMID:16272459 PMID:27588890 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
Butylated Hydroxytoluene inhibits the reaction [cholestane-3,5,6-triol results in decreased activity of CAT protein] |
CTD |
PMID:9306888 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccdc116 |
coiled-coil domain containing 116 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of CCDC116 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr11:83,842,707...83,850,607
Ensembl chr11:83,845,557...83,850,607
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of CCL17 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr19:10,202,317...10,203,768
Ensembl chr19:10,202,128...10,203,819
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases secretion increases expression |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein] Butylated Hydroxytoluene results in increased secretion of CCL2 protein Butylated Hydroxytoluene results in increased expression of CCL2 protein |
CTD |
PMID:16443645 PMID:16822543 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
decreases expression |
ISO |
Butylated Hydroxytoluene results in decreased expression of CCL5 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr10:68,322,826...68,327,365
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccna2 |
cyclin A2 |
increases expression |
ISO |
[Butylated Hydroxytoluene results in increased expression of FOXM1 mRNA] which results in increased expression of CCNA2 mRNA; Butylated Hydroxytoluene results in increased expression of CCNA2 mRNA |
CTD |
PMID:12867420 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression |
ISO |
[Butylated Hydroxytoluene results in increased expression of FOXM1 mRNA] which results in increased expression of CCNB1 mRNA; Butylated Hydroxytoluene results in increased expression of CCNB1 mRNA |
CTD |
PMID:12867420 PMID:19000923 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
ISO |
[Butylated Hydroxytoluene co-treated with Oxygen] results in increased expression of CCND1 protein |
CTD |
PMID:16272459 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
increases expression |
ISO |
[Butylated Hydroxytoluene results in increased expression of FOXM1 mRNA] which results in increased expression of CCNE1 mRNA; Butylated Hydroxytoluene results in increased expression of CCNE1 mRNA |
CTD |
PMID:12867420 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccnf |
cyclin F |
increases expression |
ISO |
[Butylated Hydroxytoluene results in increased expression of FOXM1 mRNA] which results in increased expression of CCNF mRNA; Butylated Hydroxytoluene results in increased expression of CCNF mRNA |
CTD |
PMID:12867420 |
|
NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101
|
|
G |
Cd19 |
CD19 molecule |
decreases expression |
ISO |
Butylated Hydroxytoluene results in decreased expression of CD19 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 1:180,987,286...180,993,920
Ensembl chr 1:180,987,286...180,993,975
|
|
G |
Cd37 |
CD37 molecule |
decreases expression |
ISO |
Butylated Hydroxytoluene results in decreased expression of CD37 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 1:95,719,171...95,724,662
Ensembl chr 1:95,719,190...95,724,648
|
|
G |
Cd3d |
CD3 delta subunit of T-cell receptor complex |
decreases expression |
ISO |
Butylated Hydroxytoluene results in decreased expression of CD3D mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 8:45,287,803...45,293,342
Ensembl chr 8:45,288,749...45,301,809
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
multiple interactions |
ISO |
[Butylated Hydroxytoluene co-treated with Methylcholanthrene] results in increased expression of CD44 mRNA alternative form |
CTD |
PMID:15390079 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd81 |
Cd81 molecule |
increases expression |
EXP |
Butylated Hydroxytoluene results in increased expression of CD81 mRNA |
CTD |
PMID:12082028 |
|
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO |
[Butylated Hydroxytoluene co-treated with Oxygen] results in decreased expression of CDH1 protein |
CTD |
PMID:16272459 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdk2ap2 |
cyclin-dependent kinase 2 associated protein 2 |
increases expression |
EXP |
Butylated Hydroxytoluene results in increased expression of CDK2AP2 mRNA |
CTD |
PMID:12082028 |
|
NCBI chr 1:201,391,056...201,393,137
Ensembl chr 1:201,391,466...201,393,137
|
|
G |
Cfi |
complement factor I |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of CFI mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 2:218,389,079...218,430,565
Ensembl chr 2:218,387,990...218,430,561
|
|
G |
Chek1 |
checkpoint kinase 1 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of CHEK1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Cldn2 |
claudin 2 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of CLDN2 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
|
|
G |
Col18a1 |
collagen type XVIII alpha 1 chain |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of COL18A1 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
|
|
G |
Cox6b2 |
cytochrome c oxidase subunit 6B2 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of COX6B2 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 1:69,094,009...69,095,312
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein] |
CTD |
PMID:16822543 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
ISO |
[Butylated Hydroxytoluene co-treated with Oxygen] affects the localization of CTNNB1 protein; [Butylated Hydroxytoluene co-treated with Oxygen] results in increased expression of CTNNB1 protein |
CTD |
PMID:16272459 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [cholestane-3,5,6-triol affects the localization of CYCS protein] |
CTD |
PMID:19121293 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression multiple interactions |
ISO |
Butylated Hydroxytoluene results in increased expression of CYP1A1 mRNA Butylated Hydroxytoluene affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:19925653 PMID:21094198 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases expression |
EXP |
Butylated Hydroxytoluene results in increased expression of CYP2B1 mRNA; Butylated Hydroxytoluene results in increased expression of CYP2B1 protein |
CTD |
PMID:15110098 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases expression |
EXP |
Butylated Hydroxytoluene results in increased expression of CYP2B2 mRNA; Butylated Hydroxytoluene results in increased expression of CYP2B2 protein |
CTD |
PMID:12082028 PMID:15110098 PMID:18539377 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of CYP2B6 mRNA |
CTD |
PMID:18570159 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
increases expression |
EXP |
Butylated Hydroxytoluene results in increased expression of CYP2C6V1 mRNA |
CTD |
PMID:18539377 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of CYP2J2 mRNA |
CTD |
PMID:24021950 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of CYP3A4 mRNA |
CTD |
PMID:18570159 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases expression |
EXP |
Butylated Hydroxytoluene results in increased expression of CYP3A9 mRNA |
CTD |
PMID:18539377 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Dcx |
doublecortin |
multiple interactions |
EXP |
Butylated Hydroxytoluene inhibits the reaction [Ethanol results in decreased expression of DCX protein] |
CTD |
PMID:17067360 |
|
NCBI chr X:107,430,767...107,573,612
Ensembl chr X:107,430,767...107,507,476
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
multiple interactions |
EXP |
Butylated Hydroxytoluene inhibits the reaction [ganglioside, GD3 results in increased secretion of DIABLO protein]; Butylated Hydroxytoluene inhibits the reaction [Hydrogen Peroxide results in increased secretion of DIABLO protein] |
CTD |
PMID:14987999 |
|
NCBI chr12:33,055,784...33,070,400
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dnajc3 |
DnaJ heat shock protein family (Hsp40) member C3 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of DNAJC3 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr15:96,025,729...96,065,114
Ensembl chr15:96,025,624...96,065,181
|
|
G |
Dock2 |
dedicator of cytokinesis 2 |
decreases expression |
ISO |
Butylated Hydroxytoluene results in decreased expression of DOCK2 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr10:18,827,237...19,244,823
Ensembl chr10:18,827,239...19,244,808
|
|
G |
Elavl1 |
ELAV like RNA binding protein 1 |
affects localization |
ISO |
Butylated Hydroxytoluene affects the localization of ELAVL1 protein |
CTD |
PMID:10900464 |
|
NCBI chr12:2,640,936...2,684,787
Ensembl chr12:2,645,061...2,684,784
|
|
G |
Eln |
elastin |
multiple interactions |
ISO |
[Oxygen co-treated with Butylated Hydroxytoluene] results in increased expression of ELN mRNA |
CTD |
PMID:10761639 |
|
NCBI chr12:21,968,544...22,011,929
Ensembl chr12:21,968,544...22,011,928
|
|
G |
Epor |
erythropoietin receptor |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of EPOR mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of EREG mRNA |
CTD |
PMID:19925653 |
|
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Evpl |
envoplakin |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of EVPL mRNA |
CTD |
PMID:19925653 |
|
NCBI chr10:101,458,421...101,474,687
Ensembl chr10:101,458,216...101,474,763
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Copper results in increased activity of F3 protein] |
CTD |
PMID:7600656 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of FOSL1 mRNA |
CTD |
PMID:19000923 PMID:19925653 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Foxf1 |
forkhead box F1 |
decreases expression |
ISO |
Butylated Hydroxytoluene results in decreased expression of FOXF1 mRNA |
CTD |
PMID:11238010 |
|
NCBI chr19:49,153,729...49,157,741
Ensembl chr19:49,153,699...49,157,738
|
|
G |
Foxm1 |
forkhead box M1 |
affects localization affects response to substance increases expression |
ISO |
Butylated Hydroxytoluene affects the localization of FOXM1 mRNA FOXM1 protein affects the susceptibility to Butylated Hydroxytoluene [Butylated Hydroxytoluene results in increased expression of FOXM1 mRNA] which results in increased expression of CCNA2 mRNA; [Butylated Hydroxytoluene results in increased expression of FOXM1 mRNA] which results in increased expression of CCNB1 mRNA; [Butylated Hydroxytoluene results in increased expression of FOXM1 mRNA] which results in increased expression of CCNE1 mRNA; [Butylated Hydroxytoluene results in increased expression of FOXM1 mRNA] which results in increased expression of CCNF mRNA; Butylated Hydroxytoluene results in increased expression of FOXM1 mRNA; Butylated Hydroxytoluene results in increased expression of FOXM1 protein |
CTD |
PMID:11238010 PMID:12867420 PMID:18345025 PMID:19672312 |
|
NCBI chr 4:161,639,561...161,652,012
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of GCLC protein |
CTD |
PMID:21536018 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gfpt2 |
glutamine-fructose-6-phosphate transaminase 2 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of GFPT2 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr10:34,115,005...34,161,329
Ensembl chr10:34,115,052...34,161,329
|
|
G |
Ggta1 |
glycoprotein alpha-galactosyltransferase 1 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of GGTA1 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 3:18,732,985...18,824,916
Ensembl chr 3:18,732,991...18,809,908
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
decreases phosphorylation |
ISO EXP |
Butylated Hydroxytoluene results in decreased phosphorylation of GJA1 protein |
CTD |
PMID:7586169 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gnmt |
glycine N-methyltransferase |
increases expression |
EXP |
Butylated Hydroxytoluene results in increased expression of GNMT mRNA |
CTD |
PMID:12082028 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
increases expression |
EXP |
Butylated Hydroxytoluene results in increased expression of GPLD1 mRNA |
CTD |
PMID:12082028 |
|
NCBI chr17:40,084,427...40,132,035
Ensembl chr17:40,084,617...40,126,939
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
multiple interactions increases activity |
EXP |
Butylated Hydroxytoluene promotes the reaction [GSTA5 protein affects the metabolism of aflatoxin B1-2,3-oxide]; Butylated Hydroxytoluene results in increased expression of and results in increased activity of GSTA5 protein Butylated Hydroxytoluene results in increased activity of GSTA5 protein |
CTD |
PMID:8198522 PMID:9328168 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
increases expression |
EXP |
Butylated Hydroxytoluene results in increased expression of GSTM2 mRNA |
CTD |
PMID:12082028 PMID:18539377 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression multiple interactions |
EXP ISO |
Butylated Hydroxytoluene results in increased expression of GSTP1 mRNA Butylated Hydroxytoluene results in increased alkylation of and results in decreased activity of GSTP1 protein |
CTD |
PMID:15110098 PMID:21536018 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
increases expression |
EXP |
Butylated Hydroxytoluene results in increased expression of GSTT1 mRNA |
CTD |
PMID:15110098 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gzma |
granzyme A |
decreases expression |
ISO |
Butylated Hydroxytoluene results in decreased expression of GZMA mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 2:44,740,638...44,752,471
Ensembl chr 2:44,740,569...44,752,493
|
|
G |
Hck |
HCK proto-oncogene, Src family tyrosine kinase |
affects expression |
EXP |
Butylated Hydroxytoluene affects the expression of HCK mRNA |
CTD |
PMID:18539377 |
|
NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693
|
|
G |
Hells |
helicase, lymphoid specific |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of HELLS mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
|
|
G |
Hexb |
hexosaminidase subunit beta |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [Butylated Hydroxytoluene results in increased secretion of HEXB protein] |
CTD |
PMID:15272608 |
|
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
increases activity |
EXP |
Butylated Hydroxytoluene results in increased activity of HMGCR protein |
CTD |
PMID:9199277 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmox1 |
heme oxygenase 1 |
affects expression increases expression |
ISO EXP |
Butylated Hydroxytoluene affects the expression of HMOX1 mRNA Butylated Hydroxytoluene results in increased expression of HMOX1 mRNA |
CTD |
PMID:8743975 PMID:12420312 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnf1a |
HNF1 homeobox A |
multiple interactions |
ISO |
[Butylated Hydroxytoluene co-treated with Oxygen] results in increased expression of HNF1A mRNA |
CTD |
PMID:16272459 |
|
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
affects localization increases expression multiple interactions |
ISO |
Butylated Hydroxytoluene affects the localization of HNRNPA1 protein Butylated Hydroxytoluene results in increased expression of HNRNPA1 protein [Butylated Hydroxytoluene co-treated with Methylcholanthrene] affects the localization of HNRNPA1 protein; [Butylated Hydroxytoluene co-treated with Methylcholanthrene] results in increased expression of HNRNPA1 protein |
CTD |
PMID:15390079 |
|
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Butylated Hydroxytoluene] affects the expression of HNRNPA2B1 protein |
CTD |
PMID:17477362 |
|
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
|
|
G |
Hnrnpd |
heterogeneous nuclear ribonucleoprotein D |
affects localization |
ISO |
Butylated Hydroxytoluene affects the localization of HNRNPD protein |
CTD |
PMID:10900464 |
|
NCBI chr14:9,615,375...9,638,975
Ensembl chr14:9,615,479...9,633,786
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
decreases methylation increases response to substance |
EXP ISO |
Butylated Hydroxytoluene results in decreased methylation of HRAS gene HRAS protein results in increased susceptibility to Butylated Hydroxytoluene |
CTD |
PMID:9780227 PMID:11599794 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of HSPA9 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in decreased expression of IL10 protein] |
CTD |
PMID:16822543 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il15 |
interleukin 15 |
affects expression |
EXP |
Butylated Hydroxytoluene affects the expression of IL15 mRNA |
CTD |
PMID:18539377 |
|
NCBI chr19:25,640,013...25,706,818
Ensembl chr19:25,640,251...25,706,820
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1A mRNA] |
CTD |
PMID:8435107 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of IL1RL1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of IL2 protein] |
CTD |
PMID:16822543 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of IL4 protein] |
CTD |
PMID:16822543 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Ilk |
integrin-linked kinase |
multiple interactions |
ISO |
[Butylated Hydroxytoluene co-treated with Oxygen] results in increased expression of ILK protein |
CTD |
PMID:16272459 |
|
NCBI chr 1:160,088,839...160,095,140
Ensembl chr 1:160,088,897...160,095,140
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of JUNB mRNA |
CTD |
PMID:19000923 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Kng2 |
kininogen 2 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of KNG1 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr11:77,913,876...77,936,247
Ensembl chr11:77,909,612...78,002,971
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
increases mutagenesis |
ISO |
Butylated Hydroxytoluene results in increased mutagenesis of KRAS gene |
CTD |
PMID:20101149 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
multiple interactions |
ISO |
[Butylated Hydroxytoluene co-treated with Oxygen] results in increased expression of LEF1 mRNA |
CTD |
PMID:16272459 |
|
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
|
|
G |
Lep |
leptin |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of LEP protein] |
CTD |
PMID:16822543 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of MAPK14 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mbp |
myelin basic protein |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of MBP mRNA |
CTD |
PMID:19925653 |
|
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
|
|
G |
Mcm3 |
minichromosome maintenance complex component 3 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of MCM3 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
|
|
G |
Mt-co2 |
mitochondrially encoded cytochrome c oxidase II |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [TNF protein results in decreased expression of COX2 protein] Butylated Hydroxytoluene inhibits the reaction [Reactive Oxygen Species results in decreased expression of COX2 protein] |
CTD |
PMID:12470298 |
|
NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
|
|
G |
Myl3 |
myosin light chain 3 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of MYL3 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 8:110,738,669...110,744,814
Ensembl chr 8:110,738,661...110,744,816
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
decreases response to substance |
ISO |
NFE2L2 protein results in decreased susceptibility to Butylated Hydroxytoluene |
CTD |
PMID:10535991 |
|
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
EXP |
Butylated Hydroxytoluene inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] |
CTD |
PMID:15713255 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO EXP |
Butylated Hydroxytoluene inhibits the reaction [AGT protein results in increased phosphorylation of NFKBIA protein]; Butylated Hydroxytoluene inhibits the reaction [DCD protein results in increased phosphorylation of NFKBIA protein] Butylated Hydroxytoluene inhibits the reaction [Cadmium Chloride results in decreased phosphorylation of NFKBIA protein]; Butylated Hydroxytoluene inhibits the reaction [Cadmium results in decreased phosphorylation of NFKBIA protein] |
CTD |
PMID:16478757 PMID:17532611 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Ngf |
nerve growth factor |
multiple interactions |
EXP |
Butylated Hydroxytoluene inhibits the reaction [Streptozocin results in increased expression of NGF mRNA] |
CTD |
PMID:9748608 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity increases expression |
EXP |
Butylated Hydroxytoluene results in increased activity of NQO1 protein Butylated Hydroxytoluene results in increased expression of NQO1 mRNA |
CTD |
PMID:16045903 PMID:20308224 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of NR1H2 mRNA] |
CTD |
PMID:17070507 |
|
NCBI chr 1:95,041,967...95,047,377
Ensembl chr 1:95,041,967...95,047,377
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of NR1H3 mRNA] |
CTD |
PMID:17070507 |
|
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions |
ISO |
Butylated Hydroxytoluene binds to and results in decreased activity of NR1I3 protein alternative form; Butylated Hydroxytoluene binds to and results in increased activity of NR1I3 protein alternative form |
CTD |
PMID:20869355 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
increases activity |
EXP |
Butylated Hydroxytoluene results in increased activity of NRAS |
CTD |
PMID:3040652 |
|
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
|
|
G |
Nrbf2 |
nuclear receptor binding factor 2 |
increases expression |
EXP |
Butylated Hydroxytoluene results in increased expression of NRBF2 mRNA |
CTD |
PMID:12082028 |
|
NCBI chr20:21,308,606...21,326,878
Ensembl chr20:21,308,576...21,326,818
|
|
G |
Nup54 |
nucleoporin 54 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of NUP54 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr14:15,617,630...15,636,029
Ensembl chr14:15,617,679...15,636,028
|
|
G |
Parn |
poly(A)-specific ribonuclease |
decreases expression |
ISO |
Butylated Hydroxytoluene results in decreased expression of PARN mRNA |
CTD |
PMID:19925653 |
|
NCBI chr10:1,410,636...1,548,573
Ensembl chr10:1,410,642...1,548,560
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Benzoyl Peroxide results in increased activity of PARP1 protein]; Butylated Hydroxytoluene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PARP1 protein] |
CTD |
PMID:2126186 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of PCNA protein |
CTD |
PMID:11238010 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Per2 |
period circadian regulator 2 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of PER2 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 9:92,007,289...92,049,551
Ensembl chr 9:92,007,296...92,049,459
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Hydrogen Peroxide results in increased expression of PGK1 protein] |
CTD |
PMID:18603805 |
|
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
|
|
G |
Phex |
phosphate regulating endopeptidase X-linked |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of PHEX mRNA |
CTD |
PMID:19000923 |
|
NCBI chr X:37,607,553...37,856,183
Ensembl chr X:37,610,760...37,854,469
|
|
G |
Pik3r5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of PIK3R5 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr10:53,132,585...53,200,663
Ensembl chr10:53,132,603...53,199,374
|
|
G |
Pknox2 |
PBX/knotted 1 homeobox 2 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of PKNOX2 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 8:36,600,633...36,863,131
Ensembl chr 8:36,600,636...36,790,940
|
|
G |
Pla2g4a |
phospholipase A2 group IVA |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of PLA2G4A protein |
CTD |
PMID:16443645 |
|
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
|
|
G |
Plat |
plasminogen activator, tissue type |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [LPA protein modified form results in decreased expression of PLAT protein]; Butylated Hydroxytoluene inhibits the reaction [LPA protein modified form results in increased expression of PLAT protein] |
CTD |
PMID:10856522 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Pomp |
proteasome maturation protein |
increases expression |
EXP |
Butylated Hydroxytoluene results in increased expression of POMP mRNA |
CTD |
PMID:12082028 |
|
NCBI chr12:7,162,098...7,174,737
Ensembl chr12:7,160,714...7,174,715
|
|
G |
Pon1 |
paraoxonase 1 |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [[Iron co-treated with Ascorbic Acid] results in decreased expression of PON1 protein] |
CTD |
PMID:16052486 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Pon2 |
paraoxonase 2 |
multiple interactions |
ISO EXP |
Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in increased expression of PON2 protein] |
CTD |
PMID:17916643 |
|
NCBI chr 4:33,389,702...33,425,186
Ensembl chr 4:33,389,714...33,425,248
|
|
G |
Pou2f1 |
POU class 2 homeobox 1 |
decreases expression |
ISO |
Butylated Hydroxytoluene results in decreased expression of POU2F1 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr13:78,120,617...78,263,306
Ensembl chr13:78,130,685...78,263,363
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of PPAR mRNA] |
CTD |
PMID:17070507 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression multiple interactions |
ISO |
Butylated Hydroxytoluene results in increased expression of PPARG mRNA Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of PPARG mRNA] |
CTD |
PMID:17070507 PMID:19925653 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prkca |
protein kinase C, alpha |
decreases expression |
ISO |
Butylated Hydroxytoluene results in decreased expression of PRKCA protein |
CTD |
PMID:7716780 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Psmc6 |
proteasome 26S subunit, ATPase 6 |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [AGT protein results in increased expression of PSMC6 protein]; Butylated Hydroxytoluene inhibits the reaction [Reactive Oxygen Species results in decreased expression of PSMC6 mRNA] Butylated Hydroxytoluene inhibits the reaction [TNF protein results in decreased expression of PSMC6 mRNA] |
CTD |
PMID:12470298 PMID:17532611 |
|
NCBI chr15:18,542,585...18,564,057
Ensembl chr15:18,542,563...18,564,055
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of PTGS1 protein |
CTD |
PMID:11696405 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression multiple interactions |
ISO EXP |
Butylated Hydroxytoluene results in increased expression of PTGS2 protein Butylated Hydroxytoluene inhibits the reaction [Ethanol results in increased expression of PTGS2 mRNA] |
CTD |
PMID:11696405 PMID:17067360 |
|
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pthlh |
parathyroid hormone-like hormone |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of PTHLH mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 4:180,188,792...180,199,847
Ensembl chr 4:180,188,792...180,199,847
|
|
G |
Rab31 |
RAB31, member RAS oncogene family |
decreases expression |
ISO |
Butylated Hydroxytoluene results in decreased expression of RAB31 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 9:105,246,712...105,382,973
Ensembl chr 9:105,246,709...105,381,253
|
|
G |
Rad21 |
RAD21 cohesin complex component |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of RAD21 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 7:83,287,867...83,314,810
Ensembl chr 7:83,287,870...83,314,817
|
|
G |
Rad51ap1 |
RAD51 associated protein 1 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of RAD51AP1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 4:159,759,454...159,772,524
Ensembl chr 4:159,759,459...159,772,524
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
Butylated Hydroxytoluene inhibits the reaction [Cadmium Chloride results in decreased activity of RELA protein]; Butylated Hydroxytoluene inhibits the reaction [Cadmium results in decreased activity of RELA protein]; Butylated Hydroxytoluene inhibits the reaction [TNF protein affects the localization of RELA protein]; Butylated Hydroxytoluene inhibits the reaction [TNF protein results in increased activity of RELA protein] |
CTD |
PMID:15713255 PMID:16478757 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rif1 |
replication timing regulatory factor 1 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of RIF1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 3:36,554,689...36,607,961
Ensembl chr 3:36,554,697...36,603,617
|
|
G |
Rnf112 |
ring finger protein 112 |
affects expression |
EXP |
Butylated Hydroxytoluene affects the expression of RNF112 mRNA |
CTD |
PMID:18539377 |
|
NCBI chr10:46,121,146...46,126,691
Ensembl chr10:46,121,148...46,126,699
|
|
G |
Sell |
selectin L |
decreases expression |
ISO |
Butylated Hydroxytoluene results in decreased expression of SELL mRNA |
CTD |
PMID:19925653 |
|
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
|
|
G |
Serpine1 |
serpin family E member 1 |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [LPA protein results in decreased expression of SERPINE1 protein]; Butylated Hydroxytoluene inhibits the reaction [LPA protein results in increased expression of SERPINE1 protein] |
CTD |
PMID:10856522 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Serpinh1 |
serpin family H member 1 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of SERPINH1 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 1:153,643,500...153,650,853
Ensembl chr 1:153,643,510...153,650,801
|
|
G |
Shisa2 |
shisa family member 2 |
decreases expression |
ISO |
Butylated Hydroxytoluene results in decreased expression of SHISA2 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr15:33,806,715...33,811,013
Ensembl chr15:33,805,958...33,811,013
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of SLC2A1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc2a3 |
solute carrier family 2 member 3 |
decreases expression |
ISO |
Butylated Hydroxytoluene results in decreased expression of SLC2A3 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
|
|
G |
Slc39a11 |
solute carrier family 39, member 11 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of SLC39A11 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr10:98,275,958...98,697,042
Ensembl chr10:98,275,960...98,611,295
|
|
G |
Slfn4 |
schlafen family member 4 |
decreases expression |
ISO |
Butylated Hydroxytoluene results in decreased expression of SLFN4 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr10:67,994,601...68,018,141
Ensembl chr10:68,000,028...68,018,138 Ensembl chr10:68,000,028...68,018,138
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
ISO |
[Butylated Hydroxyanisole co-treated with Butylated Hydroxytoluene] results in decreased expression of SOD2 mRNA |
CTD |
PMID:14981915 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Spib |
Spi-B transcription factor |
decreases expression |
ISO |
Butylated Hydroxytoluene results in decreased expression of SPIB mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 1:95,018,939...95,024,804
Ensembl chr 1:95,018,947...95,024,780
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of SPP1 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Srsf1 |
serine and arginine rich splicing factor 1 |
multiple interactions increases expression affects localization |
ISO |
[Butylated Hydroxytoluene co-treated with Methylcholanthrene] affects the localization of SRSF1 protein; [Butylated Hydroxytoluene co-treated with Methylcholanthrene] results in increased expression of SRSF1 protein Butylated Hydroxytoluene results in increased expression of SRSF1 protein Butylated Hydroxytoluene affects the localization of SRSF1 protein |
CTD |
PMID:15390079 |
|
NCBI chr10:72,838,926...72,859,066
Ensembl chr10:72,839,274...72,845,336
|
|
G |
Stmn1 |
stathmin 1 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of STMN1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
|
|
G |
Stom |
stomatin |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of STOM mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 3:18,645,058...18,667,343
Ensembl chr 3:18,644,378...18,667,354
|
|
G |
Tac1 |
tachykinin, precursor 1 |
multiple interactions |
EXP |
Butylated Hydroxytoluene inhibits the reaction [Streptozocin results in increased expression of TAC1 mRNA] |
CTD |
PMID:9748608 |
|
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
|
|
G |
Tdo2 |
tryptophan 2,3-dioxygenase |
affects expression increases expression |
EXP ISO |
Butylated Hydroxytoluene affects the expression of TDO2 mRNA Butylated Hydroxytoluene results in increased expression of TDO2 mRNA |
CTD |
PMID:18539377 PMID:19925653 |
|
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
|
|
G |
Tfrc |
transferrin receptor |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of TFRC mRNA |
CTD |
PMID:19000923 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tgfa |
transforming growth factor alpha |
decreases response to substance |
EXP |
Butylated Hydroxytoluene results in decreased susceptibility to TGFA protein |
CTD |
PMID:7593635 |
|
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] |
CTD |
PMID:16757516 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Thpo |
thrombopoietin |
multiple interactions |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of THPO protein] |
CTD |
PMID:16822543 |
|
Ensembl chr11:80,182,820...80,188,167
|
|
G |
Tmem45b |
transmembrane protein 45b |
decreases expression |
ISO |
Butylated Hydroxytoluene results in decreased expression of TMEM45B mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 8:29,865,276...29,910,453
Ensembl chr 8:29,865,278...29,910,453
|
|
G |
Tnc |
tenascin C |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of TNC mRNA |
CTD |
PMID:19925653 |
|
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases response to substance decreases expression |
ISO EXP |
Butylated Hydroxytoluene inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Butylated Hydroxytoluene inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Butylated Hydroxytoluene inhibits the reaction [TNF protein results in decreased expression of ATP6V1A protein]; Butylated Hydroxytoluene inhibits the reaction [TNF protein results in decreased expression of COX2 protein]; Butylated Hydroxytoluene inhibits the reaction [TNF protein results in decreased expression of PSMC6 mRNA] Butylated Hydroxytoluene results in increased susceptibility to TNF protein Butylated Hydroxytoluene inhibits the reaction [TNF protein affects the localization of RELA protein]; Butylated Hydroxytoluene inhibits the reaction [TNF protein results in decreased uptake of Excitatory Amino Acid Agents]; Butylated Hydroxytoluene inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]; Butylated Hydroxytoluene inhibits the reaction [TNF protein results in increased activity of RELA protein] Butylated Hydroxytoluene inhibits the reaction [Dextran Sulfate promotes the reaction [Ascorbic Acid promotes the reaction [Quartz results in increased secretion of TNF protein]]]; Butylated Hydroxytoluene inhibits the reaction [Dextran Sulfate promotes the reaction [Quartz results in increased secretion of TNF protein]]; Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of TNF protein] Butylated Hydroxytoluene results in decreased expression of TNF protein |
CTD |
PMID:9721806 PMID:12470298 PMID:15713255 PMID:16822543 PMID:16910777 PMID:19298665 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
EXP |
Butylated Hydroxytoluene results in increased expression of TP53 mRNA |
CTD |
PMID:9780227 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Ttr |
transthyretin |
increases expression |
EXP |
Butylated Hydroxytoluene results in increased expression of TTR mRNA |
CTD |
PMID:12082028 |
|
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
|
|
G |
Ube2g2 |
ubiquitin-conjugating enzyme E2G 2 |
increases expression |
ISO |
Butylated Hydroxytoluene results in increased expression of UBE2G2 mRNA |
CTD |
PMID:19925653 |
|
NCBI chr20:10,983,734...11,005,468
Ensembl chr20:10,983,742...11,005,447
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions increases expression |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of VEGFA protein] Butylated Hydroxytoluene results in increased expression of VEGFA mRNA |
CTD |
PMID:16822543 PMID:19000923 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Bche |
butyrylcholinesterase |
increases hydrolysis multiple interactions |
ISO |
BCHE protein results in increased hydrolysis of phenyl acetate phenyl acetate inhibits the reaction [BCHE protein results in increased hydrolysis of benzoylthiocholine] |
CTD |
PMID:31247192 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Pon1 |
paraoxonase 1 |
affects hydrolysis increases hydrolysis affects metabolic processing multiple interactions |
ISO EXP |
PON1 3' UTR SNP affects the hydrolysis of phenyl acetate; PON1 intron SNP affects the hydrolysis of phenyl acetate; PON1 promoter SNP affects the hydrolysis of phenyl acetate PON1 protein results in increased hydrolysis of phenyl acetate PON1 SNP affects the metabolism of phenyl acetate [Alendronate results in decreased activity of PON1 protein] which results in decreased metabolism of phenyl acetate; [Clodronic Acid results in decreased activity of PON1 protein] which results in decreased metabolism of phenyl acetate; [Ibandronic Acid results in decreased activity of PON1 protein] which results in decreased metabolism of phenyl acetate; [Pamidronate results in decreased activity of PON1 protein] which results in decreased metabolism of phenyl acetate; [Risedronic Acid results in increased activity of PON1 protein] which results in increased metabolism of phenyl acetate; [Zoledronic Acid results in increased activity of PON1 protein] which results in increased metabolism of phenyl acetate [Polyethylene Glycols binds to PON1 protein] which results in increased hydrolysis of phenyl acetate |
CTD |
PMID:20839225 PMID:22414384 PMID:25027835 PMID:27387541 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Pon2 |
paraoxonase 2 |
affects hydrolysis |
ISO |
PON2 gene SNP affects the hydrolysis of phenyl acetate |
CTD |
PMID:20839225 |
|
NCBI chr 4:33,389,702...33,425,186
Ensembl chr 4:33,389,714...33,425,248
|
|
G |
Pon3 |
paraoxonase 3 |
affects hydrolysis |
ISO |
PON3 gene SNP affects the hydrolysis of phenyl acetate |
CTD |
PMID:20839225 |
|
NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
|
|
G |
Ppp1r9a |
protein phosphatase 1, regulatory subunit 9A |
affects hydrolysis |
ISO |
PPP1R9A 3' UTR SNP affects the hydrolysis of phenyl acetate |
CTD |
PMID:20839225 |
|
NCBI chr 4:32,970,501...33,292,360
Ensembl chr 4:33,024,450...33,286,907
|
|
|
G |
Alb |
albumin |
multiple interactions |
ISO |
ALB protein binds to and affects the transport of salicin |
CTD |
PMID:8831264 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Tas2r118 |
taste receptor, type 2, member 118 |
multiple interactions increases activity |
ISO |
4-((diethylamino)sulfonyl)benzoic acid inhibits the reaction [salicin results in increased activity of TAS2R16 protein]; Probenecid inhibits the reaction [salicin results in increased activity of TAS2R16 protein] |
CTD |
PMID:21629661 |
|
NCBI chr 4:52,449,208...52,450,107
Ensembl chr 4:52,449,208...52,450,107
|
|
|
G |
Alb |
albumin |
multiple interactions |
ISO |
ALB protein binds to and affects the transport of salicyl alcohol |
CTD |
PMID:8831264 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Bche |
butyrylcholinesterase |
multiple interactions |
ISO |
[2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide binds to and results in decreased activity of BCHE protein] which results in increased abundance of salicyl alcohol |
CTD |
PMID:22898212 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
EXP |
salicyl alcohol inhibits the reaction [2,2'-azobis(2-amidinopropane) results in decreased activity of SOD2 protein] |
CTD |
PMID:19665455 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
|
G |
P2rx1 |
purinergic receptor P2X 1 |
affects binding |
EXP |
TNP-ATP binds to P2rx1 protein |
RGD |
PMID:12237343 |
RGD:727431 |
NCBI chr10:57,618,586...57,633,648
Ensembl chr10:57,618,586...57,633,623
|
|
G |
P2rx2 |
purinergic receptor P2X 2 |
multiple interactions |
EXP |
TNP-ATP binds to P2rx2 protein; TNP-ATP inhibits the reaction [ATP binds to P2rx2 protein] in transfected glial cells |
RGD |
PMID:16388598 |
RGD:1642662 |
NCBI chr12:46,338,979...46,342,891
Ensembl chr12:46,339,549...46,342,891
|
|
G |
P2rx5 |
purinergic receptor P2X 5 |
affects transport |
EXP |
TNP-ATP affects transport ion flux of P2rx5 receptor |
RGD |
PMID:12237343 |
RGD:727431 |
NCBI chr10:57,777,737...57,789,426
Ensembl chr10:57,777,819...57,789,423
|
|
|
G |
Aacs |
acetoacetyl-CoA synthetase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AACS mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:31,113,098...31,156,411
Ensembl chr12:31,113,098...31,160,954
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of ABCA1 mRNA |
CTD |
PMID:31724879 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in increased expression of ABCB11 mRNA |
CTD |
PMID:32360330 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ABCB1A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ABCB4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcb9 |
ATP binding cassette subfamily B member 9 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ABCB9 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:32,499,225...32,531,932
Ensembl chr12:32,499,225...32,531,931
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ABCC2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ABCC3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ABCC4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcd2 |
ATP binding cassette subfamily D member 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ABCD2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:122,263,034...122,311,642
Ensembl chr 7:122,263,032...122,311,642
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
multiple interactions decreases expression |
ISO |
triphenyl phosphate inhibits the reaction [T0901317 results in increased expression of ABCG1 mRNA] triphenyl phosphate results in decreased expression of ABCG1 mRNA |
CTD |
PMID:31724879 |
|
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ABCG5 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Abcg8 |
ATP binding cassette subfamily G member 8 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ABCG8 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
|
|
G |
Abhd1 |
abhydrolase domain containing 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ABHD1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:25,422,526...25,427,514
Ensembl chr 6:25,422,526...25,427,514
|
|
G |
Abhd5 |
abhydrolase domain containing 5, lysophosphatidic acid acyltransferase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ABHD5 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:122,000,241...122,026,447
Ensembl chr 8:122,000,389...122,026,447
|
|
G |
Abi3bp |
ABI family member 3 binding protein |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ABI3BP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:43,912,187...44,128,888
Ensembl chr11:43,913,043...44,128,929
|
|
G |
Ablim1 |
actin-binding LIM protein 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ABLIM1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:256,084,293...256,372,075
Ensembl chr 1:256,084,297...256,371,969
|
|
G |
Ablim3 |
actin binding LIM protein family, member 3 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ABLIM3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:55,256,135...55,376,629
Ensembl chr18:55,257,583...55,376,380
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ACACA mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acad9 |
acyl-CoA dehydrogenase family, member 9 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ACAD9 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ACAT2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
|
|
G |
Acer2 |
alkaline ceramidase 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ACER2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:101,391,830...101,442,615
Ensembl chr 5:101,391,885...101,442,614
|
|
G |
Acly |
ATP citrate lyase |
affects expression |
EXP |
triphenyl phosphate affects the expression of ACLY mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
|
|
G |
Aco1 |
aconitase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ACO1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ACOT4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
|
|
G |
Acox3 |
acyl-CoA oxidase 3, pristanoyl |
affects expression |
EXP |
triphenyl phosphate affects the expression of ACOX3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:75,133,986...75,176,767
Ensembl chr14:75,094,676...75,176,205
|
|
G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ACSL5 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:254,289,513...254,336,608
Ensembl chr 1:254,292,521...254,336,607
|
|
G |
Acsm2 |
acyl-CoA synthetase medium-chain family member 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ACSM2A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:173,916,368...173,955,116
Ensembl chr 1:173,916,368...173,955,116
|
|
G |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ACSM3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
|
|
G |
Acsm5 |
acyl-CoA synthetase medium-chain family member 5 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ACSM5 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:173,870,873...173,896,838
Ensembl chr 1:173,863,041...173,898,588
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ACSS2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
|
|
G |
Actg1 |
actin, gamma 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ACTG1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232
|
|
G |
Acy3 |
aminoacylase 3 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ACY3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:201,279,751...201,285,803
Ensembl chr 1:201,279,851...201,283,175
|
|
G |
Acyp1 |
acylphosphatase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ACYP1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:104,919,162...104,932,348
Ensembl chr 6:104,919,162...104,932,387
|
|
G |
Acyp2 |
acylphosphatase 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ACYP2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:104,201,894...104,371,415
Ensembl chr14:104,201,895...104,371,386
|
|
G |
Adam11 |
ADAM metallopeptidase domain 11 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ADAM11 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:87,724,115...87,742,773
Ensembl chr10:87,724,234...87,741,562
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ADAMTS1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Adamts7 |
ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ADAMTS7 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:90,704,727...90,744,331
Ensembl chr 8:90,704,727...90,744,328
|
|
G |
Adamts9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ADAMTS9 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:125,290,633...125,462,988
Ensembl chr 4:125,291,490...125,462,929
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ADGRE1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000
|
|
G |
Adgrg2 |
adhesion G protein-coupled receptor G2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ADGRG2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr X:34,297,402...34,422,590
Ensembl chr X:34,297,402...34,422,609
|
|
G |
Adh1 |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
affects expression |
EXP |
triphenyl phosphate affects the expression of ADH1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ADH4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
affects expression |
EXP |
triphenyl phosphate affects the expression of ADH7 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
increases expression multiple interactions |
ISO |
triphenyl phosphate results in increased expression of ADIPOQ mRNA [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased secretion of ADIPOQ protein |
CTD |
PMID:28934090 PMID:34323617 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adm |
adrenomedullin |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of ADM mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adm2 |
adrenomedullin 2 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ADM2 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 7:120,393,219...120,394,965
Ensembl chr 7:120,393,179...120,396,331
|
|
G |
Adra2b |
adrenoceptor alpha 2B |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ADRA2B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:114,585,174...114,589,220
Ensembl chr 3:114,585,169...114,589,355
|
|
G |
Adss1 |
adenylosuccinate synthase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ADSSL1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:131,679,795...131,702,012
Ensembl chr 6:131,679,701...131,701,998
|
|
G |
Afmid |
arylformamidase |
affects expression |
EXP |
triphenyl phosphate affects the expression of AFMID mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:103,046,129...103,061,718
Ensembl chr10:103,046,180...103,061,718
|
|
G |
Agrp |
agouti related neuropeptide |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of AGRP mRNA; [tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in increased expression of AGRP mRNA |
CTD |
PMID:29112739 PMID:32360330 |
|
NCBI chr19:33,447,992...33,523,068
Ensembl chr19:33,447,992...33,449,584
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of AGTR1A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Agxt |
alanine--glyoxylate aminotransferase |
affects expression |
EXP |
triphenyl phosphate affects the expression of AGXT mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:93,675,384...93,685,337
Ensembl chr 9:93,675,384...93,685,336
|
|
G |
Ak3 |
adenylate kinase 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AK3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
|
|
G |
Ak4 |
adenylate kinase 4 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of AK4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
|
|
G |
Akap13 |
A-kinase anchoring protein 13 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AKAP13 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:129,313,183...129,619,647
Ensembl chr 1:129,314,402...129,619,646
|
|
G |
Akap2 |
A-kinase anchoring protein 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of AKAP2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:72,536,986...72,648,524
Ensembl chr 5:72,181,718...72,648,524
|
|
G |
Akr1b7 |
aldo-keto reductase family 1, member B7 |
affects expression |
EXP |
triphenyl phosphate affects the expression of AKR1B7 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:63,053,560...63,100,934
Ensembl chr 4:63,076,800...63,089,502
|
|
G |
Akr7a2 |
aldo-keto reductase family 7, member A2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AKR7A2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AKR7A3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Alas1 |
5'-aminolevulinate synthase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ALAS1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:106,876,514...106,889,852
Ensembl chr 8:106,876,514...106,889,917
|
|
G |
Alas2 |
5'-aminolevulinate synthase 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ALAS2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr X:19,463,146...19,486,526
Ensembl chr X:19,463,171...19,486,519
|
|
G |
Alb |
albumin |
decreases secretion |
EXP |
triphenyl phosphate results in decreased secretion of ALB protein |
CTD |
PMID:30589522 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Alcam |
activated leukocyte cell adhesion molecule |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ALCAM mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ALDH1A3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AMIGO2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
|
|
G |
Amz1 |
archaelysin family metallopeptidase 1 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of AMZ1 mRNA |
CTD |
PMID:28934090 |
|
NCBI chr12:13,886,533...13,924,275
Ensembl chr12:13,891,123...13,909,783
|
|
G |
Angptl4 |
angiopoietin-like 4 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ANGPTL4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Ankrd33b |
ankyrin repeat domain 33B |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ANKRD33B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:82,277,604...82,359,420
Ensembl chr 2:82,283,108...82,358,872
|
|
G |
Ankrd46 |
ankyrin repeat domain 46 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ANKRD46 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:67,647,202...67,668,180
Ensembl chr 7:67,647,204...67,668,132
|
|
G |
Anxa1 |
annexin A1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ANXA1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa3 |
annexin A3 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ANXA3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
|
|
G |
Anxa7 |
annexin A7 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ANXA7 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr15:3,821,798...3,849,659
Ensembl chr15:3,821,845...3,849,385
|
|
G |
Aox1 |
aldehyde oxidase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AOX1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
|
|
G |
Ap3m1 |
adaptor related protein complex 3 subunit mu 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AP3M1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr15:3,246,616...3,264,846
Ensembl chr15:3,246,926...3,264,844
|
|
G |
Aplf |
aprataxin and PNKP like factor |
increases expression |
EXP |
triphenyl phosphate results in increased expression of APLF mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:120,070,471...120,122,656
Ensembl chr 4:120,070,471...120,122,633
|
|
G |
Aplnr |
apelin receptor |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of APLNR mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 3:70,217,407...70,221,052
Ensembl chr 3:70,217,385...70,221,050
|
|
G |
Apoa4 |
apolipoprotein A4 |
affects expression |
EXP |
triphenyl phosphate affects the expression of APOA4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Apoe |
apolipoprotein E |
affects response to substance |
ISO |
APOE protein affects the susceptibility to triphenyl phosphate |
CTD |
PMID:31724879 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
App |
amyloid beta precursor protein |
increases expression |
EXP |
triphenyl phosphate results in increased expression of APP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Aqp7 |
aquaporin 7 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AQP7 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:56,172,519...56,186,642
|
|
G |
Aqp9 |
aquaporin 9 |
affects expression |
EXP |
triphenyl phosphate affects the expression of AQP9 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
|
|
G |
Ar |
androgen receptor |
affects binding multiple interactions decreases activity |
EXP ISO |
triphenyl phosphate binds to AR protein triphenyl phosphate binds to and results in decreased activity of AR protein; triphenyl phosphate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; triphenyl phosphate inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; triphenyl phosphate metabolite inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein] triphenyl phosphate results in decreased activity of AR protein |
CTD |
PMID:14565775 PMID:23398518 PMID:24051214 PMID:26778350 PMID:28728110 PMID:33049310 More...
|
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arhgap24 |
Rho GTPase activating protein 24 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ARHGAP24 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:6,800,631...7,184,001
Ensembl chr14:6,800,631...7,183,823
|
|
G |
Arhgef26 |
Rho guanine nucleotide exchange factor 26 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ARHGEF26 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:146,740,336...146,850,918
Ensembl chr 2:146,739,631...146,850,819
|
|
G |
Arid5b |
AT-rich interaction domain 5B |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ARID5B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:20,307,731...20,490,746
Ensembl chr20:20,307,731...20,487,433
|
|
G |
Armc9 |
armadillo repeat containing 9 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ARMC9 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:86,802,791...86,928,860
Ensembl chr 9:86,802,868...86,928,860
|
|
G |
Arpp19 |
cAMP-regulated phosphoprotein 19 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ARPP19 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:75,779,640...75,802,474
Ensembl chr 8:75,779,523...75,802,452
|
|
G |
Arsb |
arylsulfatase B |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ARSB mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:25,002,210...25,162,675
Ensembl chr 2:25,002,346...25,162,671
|
|
G |
Arsl |
arylsulfatase L |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ARSL mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:119,038,803...119,047,579
Ensembl chr 2:119,038,921...119,046,846
|
|
G |
Asb5 |
ankyrin repeat and SOCS box-containing 5 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ASB5 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:37,237,869...37,305,207
Ensembl chr16:37,235,405...37,278,109
|
|
G |
Asl |
argininosuccinate lyase |
affects expression |
EXP |
triphenyl phosphate affects the expression of ASL mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
increases expression multiple interactions |
EXP ISO |
triphenyl phosphate results in increased expression of ASNS mRNA [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ASNS mRNA |
CTD |
PMID:30589522 PMID:33367866 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Atf4 |
activating transcription factor 4 |
increases expression multiple interactions |
EXP ISO |
triphenyl phosphate results in increased expression of ATF4 mRNA [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ATF4 mRNA |
CTD |
PMID:30589522 PMID:33367866 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ATF6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atoh8 |
atonal bHLH transcription factor 8 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ATOH8 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:104,259,992...104,292,168
Ensembl chr 4:104,259,992...104,292,168
|
|
G |
Atp6v1c2 |
ATPase H+ transporting V1 subunit C2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ATP6V1C2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:40,080,545...40,144,199
Ensembl chr 6:40,080,547...40,120,028
|
|
G |
Atp8a1 |
ATPase phospholipid transporting 8A1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ATP8A1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:40,315,013...40,557,572
Ensembl chr14:40,315,049...40,554,611
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ATP8B1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:58,016,382...58,157,213
Ensembl chr18:58,018,268...58,157,396
|
|
G |
Atrn |
attractin |
affects expression |
EXP |
triphenyl phosphate affects the expression of ATRN mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:118,110,320...118,244,326
Ensembl chr 3:118,110,229...118,244,322
|
|
G |
Aurkb |
aurora kinase B |
affects expression |
EXP |
triphenyl phosphate affects the expression of AURKB mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
Avpi1 |
arginine vasopressin-induced 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AVPI1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:240,930,236...240,936,154
Ensembl chr 1:240,930,236...240,936,154
|
|
G |
Avpr1a |
arginine vasopressin receptor 1A |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of AVPR1A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215
|
|
G |
Axin2 |
axin 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of AXIN2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
|
|
G |
Axl |
Axl receptor tyrosine kinase |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of AXL mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:81,265,656...81,296,278
Ensembl chr 1:81,265,088...81,296,265
|
|
G |
B3gnt2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of B3GNT2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:96,808,473...96,833,674
Ensembl chr14:96,806,664...96,835,273
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of BBC3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcar3 |
BCAR3 adaptor protein, NSP family member |
increases expression |
EXP |
triphenyl phosphate results in increased expression of BCAR3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:210,525,260...210,638,674
Ensembl chr 2:210,525,260...210,638,798
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of BCL2A1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of BCL2L11 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl6b |
BCL6B, transcription repressor |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of BCL6B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:54,940,908...54,947,022
Ensembl chr10:54,940,909...54,945,974
|
|
G |
Bdh2 |
3-hydroxybutyrate dehydrogenase 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of BDH2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
|
|
G |
Bgn |
biglycan |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of BGN mRNA |
CTD |
PMID:30589522 |
|
NCBI chr X:151,197,296...151,209,458
Ensembl chr X:151,197,273...151,209,461
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of BHMT mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
Blm |
BLM RecQ like helicase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of BLM mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:134,409,832...134,496,073
Ensembl chr 1:134,409,857...134,484,312
|
|
G |
Bmal1 |
basic helix-loop-helix ARNT like 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of BMAL1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
|
|
G |
Bpifb4 |
BPI fold containing family B, member 4 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of BPIFB4 mRNA |
CTD |
PMID:28934090 |
|
NCBI chr 3:142,423,571...142,448,044
Ensembl chr 3:142,400,976...142,448,044
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of BUB1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
C1qa |
complement C1q A chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of C1QA mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
|
|
G |
C1qc |
complement C1q C chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of C1QC mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:149,127,424...149,130,732
Ensembl chr 5:149,127,415...149,131,017
|
|
G |
C2h4orf46 |
similar to human chromosome 4 open reading frame 46 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of C2H4ORF46 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:164,762,994...164,766,126
Ensembl chr 2:164,762,960...164,766,128
|
|
G |
C3ar1 |
complement C3a receptor 1 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of C3AR1 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
|
|
G |
C8h11orf54 |
similar to human chromosome 11 open reading frame 54 |
affects expression |
EXP |
triphenyl phosphate affects the expression of C8H11ORF54 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473
|
|
G |
Cabcoco1 |
ciliary associated calcium binding coiled-coil 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CABCOCO1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:20,058,492...20,167,973
Ensembl chr20:20,058,454...20,167,725
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1G mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1G mRNA] |
CTD |
PMID:29112739 |
|
NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752
|
|
G |
Cacna1h |
calcium voltage-gated channel subunit alpha1 H |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1H mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1H mRNA] |
CTD |
PMID:29112739 |
|
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
|
|
G |
Cacna1i |
calcium voltage-gated channel subunit alpha1 I |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1I mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1I mRNA] |
CTD |
PMID:29112739 |
|
NCBI chr 7:111,835,996...111,947,418
Ensembl chr 7:111,836,012...111,944,688
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CADM1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
|
|
G |
Calr3 |
calreticulin 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CALR3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:17,396,064...17,423,166
Ensembl chr16:17,396,247...17,423,015
|
|
G |
Caprin2 |
caprin family member 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CAPRIN2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:181,806,105...181,860,754
Ensembl chr 4:181,806,575...181,860,830
|
|
G |
Car1 |
carbonic anhydrase 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CA1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:86,829,436...86,872,209
Ensembl chr 2:86,861,897...86,872,208
|
|
G |
Car3 |
carbonic anhydrase 3 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CAR3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Cartpt |
CART prepropeptide |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of CARTPT mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of CARTPT mRNA] |
CTD |
PMID:29112739 |
|
NCBI chr 2:31,255,098...31,257,452
Ensembl chr 2:31,255,098...31,290,713
|
|
G |
Casp3 |
caspase 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CASP3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CASP4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Cat |
catalase |
increases expression increases activity |
ISO EXP |
triphenyl phosphate results in increased expression of CAT mRNA; triphenyl phosphate results in increased expression of CAT protein triphenyl phosphate results in increased activity of CAT protein |
CTD |
PMID:26049154 PMID:26183808 PMID:30974155 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cav2 |
caveolin 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CAV2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:45,616,766...45,624,144
Ensembl chr 4:45,616,712...45,624,244
|
|
G |
Cbr4 |
carbonyl reductase 4 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CBR4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:28,629,928...28,684,230
Ensembl chr16:28,617,224...28,645,712
|
|
G |
Cbs |
cystathionine beta synthase |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CBS mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
|
|
G |
Cbx5 |
chromobox 5 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CBX5 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:134,333,165...134,376,102
Ensembl chr 7:134,331,335...134,375,022
|
|
G |
Cc2d2a |
coiled-coil and C2 domain containing 2A |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CC2D2A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:67,349,004...67,435,883
Ensembl chr14:67,351,353...67,435,949
|
|
G |
Ccdc17 |
coiled-coil domain containing 17 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CCDC17 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:130,051,158...130,056,676
Ensembl chr 5:130,045,938...130,056,673
|
|
G |
Ccdc80 |
coiled-coil domain containing 80 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CCDC80 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:55,685,165...55,718,827
Ensembl chr11:55,685,872...55,719,137
|
|
G |
Ccl24 |
C-C motif chemokine ligand 24 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CCL24 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:21,100,835...21,104,832
Ensembl chr12:21,100,835...21,104,893
|
|
G |
Ccl9 |
C-C motif chemokine ligand 9 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CCL6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
|
|
G |
Ccn2 |
cellular communication network factor 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CCN2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccng2 |
cyclin G2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CCNG2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Ccser2 |
coiled-coil serine-rich protein 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CCSER2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:12,613,103...12,725,764
Ensembl chr16:12,613,103...12,725,738
|
|
G |
Cd14 |
CD14 molecule |
increases expression |
ISO |
triphenyl phosphate results in increased expression of CD14 mRNA |
CTD |
PMID:35752650 |
|
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd163 |
CD163 molecule |
decreases expression increases expression |
EXP ISO |
triphenyl phosphate results in decreased expression of CD163 mRNA triphenyl phosphate results in increased expression of CD163 mRNA |
CTD |
PMID:30589522 PMID:35752650 |
|
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of CD36 mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of CD36 mRNA] |
CTD |
PMID:29112739 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd46 |
CD46 molecule |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CD46 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:106,575,586...106,606,325
Ensembl chr13:106,574,858...106,660,445
|
|
G |
Cd5l |
Cd5 molecule-like |
affects expression |
EXP |
triphenyl phosphate affects the expression of CD5L mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:172,791,007...172,802,018
Ensembl chr 2:172,790,934...172,829,753
|
|
G |
Cd74 |
CD74 molecule |
affects expression |
EXP |
triphenyl phosphate affects the expression of CD74 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cd93 |
CD93 molecule |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CD93 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:135,891,859...135,898,378
Ensembl chr 3:135,891,859...135,898,378
|
|
G |
Cdc25b |
cell division cycle 25B |
affects expression |
EXP |
triphenyl phosphate affects the expression of CDC25B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272
|
|
G |
Cdc42ep3 |
CDC42 effector protein 3 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CDC42EP3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:15,710,894...15,731,366
Ensembl chr 6:15,708,730...15,732,721
|
|
G |
Cdh5 |
cadherin 5 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of CDH5 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
|
|
G |
Cdhr1 |
cadherin-related family member 1 |
increases expression |
ISO |
triphenyl phosphate results in increased expression of CDHR1 mRNA |
CTD |
PMID:28934090 |
|
NCBI chr16:12,843,436...12,863,321
Ensembl chr16:12,843,437...12,863,396
|
|
G |
Cdk14 |
cyclin-dependent kinase 14 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CDK14 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:28,666,688...29,258,865
Ensembl chr 4:28,666,843...29,258,861
|
|
G |
Cdkl2 |
cyclin dependent kinase like 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CDKL2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:16,027,381...16,063,257
Ensembl chr14:16,028,363...16,063,252
|
|
G |
Cdkl4 |
cyclin-dependent kinase-like 4 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CDKL4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:14,449,822...14,492,568
Ensembl chr 6:14,450,681...14,492,046
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CDKN1A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn2aipnl |
CDKN2A interacting protein N-terminal like |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CDKN2AIPNL mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:36,231,134...36,240,569
Ensembl chr10:36,231,087...36,240,564
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CDT1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CEACAM1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
increases expression multiple interactions |
ISO |
triphenyl phosphate results in increased expression of CEBPA mRNA [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of CEBPA mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of CEBPA mRNA |
CTD |
PMID:28163246 PMID:28437481 PMID:28934090 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases expression |
ISO |
triphenyl phosphate results in increased expression of CEBPB mRNA |
CTD |
PMID:28163246 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
increases expression affects expression |
ISO EXP |
triphenyl phosphate results in increased expression of CEBPD mRNA triphenyl phosphate affects the expression of CEBPD mRNA |
CTD |
PMID:28163246 PMID:30589522 |
|
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
|
|
G |
Cela1 |
chymotrypsin like elastase 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CELA1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:131,773,161...131,786,300
Ensembl chr 7:131,742,002...131,786,285
|
|
G |
Cenpk |
centromere protein K |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CENPK mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:35,360,132...35,421,372
Ensembl chr 2:35,360,132...35,385,706
|
|
G |
Cenpl |
centromere protein L |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CENPL mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:73,337,235...73,352,115
Ensembl chr13:73,337,257...73,352,114
|
|
G |
Cep104 |
centrosomal protein 104 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CEP104 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:164,534,773...164,567,260
Ensembl chr 5:164,534,782...164,567,248
|
|
G |
Cep164 |
centrosomal protein 164 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CEP164 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:46,070,901...46,134,511
Ensembl chr 8:46,071,076...46,134,336
|
|
G |
Cers6 |
ceramide synthase 6 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CERS6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:53,630,636...53,879,692
Ensembl chr 3:53,630,959...53,876,848
|
|
G |
Ces1d |
carboxylesterase 1D |
multiple interactions decreases expression decreases activity |
ISO EXP |
triphenyl phosphate inhibits the reaction [CES1 protein results in increased metabolism of and results in increased activity of imidapril] triphenyl phosphate results in decreased expression of CES1D mRNA triphenyl phosphate results in decreased activity of CES1 protein |
CTD |
PMID:30589522 PMID:31268531 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Cfap20 |
cilia and flagella associated protein 20 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CFAP20 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:9,608,851...9,622,562
Ensembl chr19:9,608,859...9,622,558
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CHAC1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Chd9 |
chromodomain helicase DNA binding protein 9 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CHD9 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:15,941,535...16,146,220
Ensembl chr19:15,942,687...16,164,556
|
|
G |
Chka |
choline kinase alpha |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CHKA mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
|
|
G |
Chmp4c |
charged multivesicular body protein 4C |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CHMP4C mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:91,391,729...91,428,652
Ensembl chr 2:91,388,530...91,428,668
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions |
ISO |
triphenyl phosphate inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]] |
CTD |
PMID:22750351 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions |
ISO |
triphenyl phosphate inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]] |
CTD |
PMID:22750351 |
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Chsy1 |
chondroitin sulfate synthase 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CHSY1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:119,689,626...119,750,711
Ensembl chr 1:119,686,350...119,750,601
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CHUK mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CIDEA mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:60,894,917...60,920,485
Ensembl chr18:60,894,874...60,920,481
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
increases expression multiple interactions |
ISO |
triphenyl phosphate results in increased expression of CIDEC mRNA [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEC mRNA |
CTD |
PMID:28934090 PMID:34323617 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Cish |
cytokine inducible SH2-containing protein |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CISH mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
|
|
G |
Clca2 |
chloride channel accessory 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CLCA2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:233,993,619...234,022,691
Ensembl chr 2:233,995,078...234,022,199
|
|
G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CLCF1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
|
|
G |
Clcn3 |
chloride voltage-gated channel 3 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CLCN3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:29,127,419...29,200,133
Ensembl chr16:29,127,419...29,200,119
|
|
G |
Cldn1 |
claudin 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CLDN1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cldn14 |
claudin 14 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CLDN14 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:33,232,281...33,329,440
Ensembl chr11:33,232,220...33,329,171
|
|
G |
Cldn5 |
claudin 5 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of CLDN5 mRNA |
CTD |
PMID:35752650 |
|
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
|
|
G |
Clec4f |
C-type lectin domain family 4, member F |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CLEC4F mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:116,129,023...116,138,744
Ensembl chr 4:116,129,023...116,138,775
|
|
G |
Clock |
clock circadian regulator |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CLOCK mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:31,908,542...31,992,673
Ensembl chr14:31,908,566...31,990,400
|
|
G |
Clpx |
caseinolytic mitochondrial matrix peptidase chaperone subunit X |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CLPX mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:65,805,460...65,845,643
Ensembl chr 8:65,805,511...65,845,082
|
|
G |
Cmip |
c-Maf-inducing protein |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CMIP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:45,304,597...45,510,653
Ensembl chr19:45,304,031...45,508,709
|
|
G |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CMTM6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:114,422,681...114,441,034
Ensembl chr 8:114,422,921...114,441,033
|
|
G |
Cmtm8 |
CKLF-like MARVEL transmembrane domain containing 8 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CMTM8 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:114,481,730...114,547,107
Ensembl chr 8:114,481,982...114,547,083
|
|
G |
Cndp2 |
carnosine dipeptidase 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CNDP2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:78,039,924...78,057,030
Ensembl chr18:78,039,932...78,056,922
|
|
G |
Cnn1 |
calponin 1 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of CNN1 mRNA |
CTD |
PMID:28934090 |
|
NCBI chr 8:20,632,434...20,641,097
Ensembl chr 8:20,632,338...20,641,098
|
|
G |
Cnnm2 |
cyclin and CBS domain divalent metal cation transport mediator 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CNNM2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:245,643,682...245,769,542
Ensembl chr 1:245,643,768...245,763,286
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CNP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
|
|
G |
Cobl |
cordon-bleu WH2 repeat protein |
increases expression |
EXP |
triphenyl phosphate results in increased expression of COBL mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:86,828,137...87,060,682
Ensembl chr14:86,828,139...87,060,800
|
|
G |
Cobll1 |
cordon-bleu WH2 repeat protein-like 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of COBLL1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:49,753,260...49,915,168
Ensembl chr 3:49,753,262...49,915,194
|
|
G |
Col10a1 |
collagen type X alpha 1 chain |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of COL10A1 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr20:38,183,103...38,189,488
Ensembl chr20:38,182,494...38,189,494
|
|
G |
Col13a1 |
collagen type XIII alpha 1 chain |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of COL13A1 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr20:29,783,965...29,924,116
Ensembl chr20:29,783,965...29,924,032
|
|
G |
Col14a1 |
collagen type XIV alpha 1 chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of COL14A1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of COL1A2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col24a1 |
collagen type XXIV alpha 1 chain |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of COL24A1 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 2:234,212,256...234,469,445
Ensembl chr 2:234,212,324...234,469,441
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of COL4A1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of COL5A1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of COL5A2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:47,448,736...47,598,396
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Col6a3 |
collagen type VI alpha 3 chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of COL6A3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:91,361,583...91,439,471
|
|
G |
Colec11 |
collectin sub-family member 11 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of COLEC11 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:45,223,974...45,256,640
Ensembl chr 6:45,223,980...45,271,145
|
|
G |
Copz2 |
COPI coat complex subunit zeta 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of COPZ2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:81,832,441...81,845,514
Ensembl chr10:81,832,418...81,845,514
|
|
G |
Corin |
corin, serine peptidase |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of CORIN mRNA |
CTD |
PMID:28934090 |
|
NCBI chr14:35,680,601...35,910,703
Ensembl chr14:35,681,304...35,909,503
|
|
G |
Coro1c |
coronin 1C |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CORO1C mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:42,712,960...42,785,179
Ensembl chr12:42,712,991...42,785,179
|
|
G |
Coro6 |
coronin 6 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CORO6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:62,311,552...62,319,659
Ensembl chr10:62,311,660...62,319,659
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of COTL1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
|
|
G |
Cpne3 |
copine 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CPNE3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:33,014,658...33,064,004
Ensembl chr 5:33,016,307...33,063,934
|
|
G |
Cpne8 |
copine 8 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CPNE8 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:121,615,293...121,789,507
Ensembl chr 7:121,615,294...121,790,377
|
|
G |
Cpped1 |
calcineurin-like phosphoesterase domain containing 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CPPED1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:3,701,522...3,821,050
Ensembl chr10:3,701,459...3,821,054
|
|
G |
Cpsf6 |
cleavage and polyadenylation specific factor 6 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CPSF6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:52,956,589...53,001,783
Ensembl chr 7:52,956,589...52,988,122
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
decreases expression affects expression |
ISO EXP |
triphenyl phosphate results in decreased expression of CPT1A mRNA triphenyl phosphate affects the expression of CPT1A mRNA |
CTD |
PMID:30589522 PMID:30966736 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cpt1b |
carnitine palmitoyltransferase 1B |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CPT1B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
increases expression |
ISO |
triphenyl phosphate results in increased expression of CPT2 mRNA |
CTD |
PMID:30966736 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Cptp |
ceramide-1-phosphate transfer protein |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CPTP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:166,474,947...166,479,103
Ensembl chr 5:166,474,966...166,479,017
|
|
G |
Crat |
carnitine O-acetyltransferase |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CRAT mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
|
|
G |
Crb3 |
crumbs cell polarity complex component 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CRB3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:1,898,531...1,903,860
Ensembl chr 9:1,896,623...1,903,859
|
|
G |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CREG1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:78,019,814...78,032,310
Ensembl chr13:78,019,843...78,032,308
|
|
G |
Crem |
cAMP responsive element modulator |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CREM mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Crim1 |
cysteine rich transmembrane BMP regulator 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CRIM1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:16,695,864...16,870,264
Ensembl chr 6:16,697,829...16,870,259
|
|
G |
Crip2 |
cysteine-rich protein 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CRIP2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:132,221,120...132,226,066
Ensembl chr 6:132,221,082...132,226,065
|
|
G |
Crot |
carnitine O-octanoyltransferase |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CROT mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109
|
|
G |
Crppa |
CDP-L-ribitol pyrophosphorylase A |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ISPD mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:53,120,264...53,397,030
Ensembl chr 6:53,121,438...53,397,028
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CRY1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
|
|
G |
Cry2 |
cryptochrome circadian regulator 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CRY2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:78,374,995...78,405,001
Ensembl chr 3:78,374,995...78,404,965
|
|
G |
Crybg3 |
crystallin beta-gamma domain containing 3 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CRYBG3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:40,749,198...40,861,753
Ensembl chr11:40,749,214...40,861,752
|
|
G |
Cryl1 |
crystallin, lambda 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CRYL1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr15:31,427,011...31,545,997
Ensembl chr15:31,427,054...31,545,997
|
|
G |
Crym |
crystallin, mu |
affects expression |
EXP |
triphenyl phosphate affects the expression of CRYM mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
affects expression multiple interactions |
EXP ISO |
triphenyl phosphate affects the expression of CSF1R mRNA [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of CSF1R mRNA |
CTD |
PMID:30589522 PMID:33367866 |
|
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csnk1d |
casein kinase 1, delta |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CSNK1D mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:106,221,992...106,256,620
Ensembl chr10:106,221,992...106,256,614
|
|
G |
Cspg5 |
chondroitin sulfate proteoglycan 5 |
increases expression |
ISO |
triphenyl phosphate results in increased expression of CSPG5 mRNA |
CTD |
PMID:35752650 |
|
NCBI chr 8:110,220,653...110,234,750
Ensembl chr 8:110,220,653...110,234,758
|
|
G |
Csrnp1 |
cysteine and serine rich nuclear protein 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CSRNP1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CSRP1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Ctf1 |
cardiotrophin 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CTF1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:182,328,035...182,336,346
Ensembl chr 1:182,328,090...182,333,335
|
|
G |
Cth |
cystathionine gamma-lyase |
decreases expression multiple interactions |
EXP ISO |
triphenyl phosphate results in decreased expression of CTH mRNA [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of CTH mRNA |
CTD |
PMID:30589522 PMID:33367866 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of CTLA4 mRNA |
CTD |
PMID:35752650 |
|
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
|
|
G |
Ctse |
cathepsin E |
affects expression |
EXP |
triphenyl phosphate affects the expression of CTSE mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:43,091,954...43,114,509
Ensembl chr13:43,092,128...43,114,502
|
|
G |
Cux2 |
cut-like homeobox 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CUX2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:34,507,723...34,707,581
Ensembl chr12:34,520,959...34,705,806
|
|
G |
Cxadr |
CXADR, Ig-like cell adhesion molecule |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CXADR mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:16,982,752...17,030,078
Ensembl chr11:16,982,860...17,030,046
|
|
G |
Cxcl11 |
C-X-C motif chemokine ligand 11 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CXCL11 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CXCR4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYBA mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cybb |
cytochrome b-245 beta chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYBB mRNA |
CTD |
PMID:30589522 |
|
NCBI chr X:13,360,583...13,392,517
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyfip2 |
cytoplasmic FMR1 interacting protein 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYFIP2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
increases expression decreases expression |
ISO |
triphenyl phosphate results in increased expression of CYP11A1 mRNA triphenyl phosphate results in decreased expression of CYP11A1 mRNA |
CTD |
PMID:22446829 PMID:26049154 PMID:26183808 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression multiple interactions |
ISO |
triphenyl phosphate results in decreased expression of CYP17A1 mRNA triphenyl phosphate inhibits the reaction [CGB3 protein results in increased expression of CYP17A1 mRNA] |
CTD |
PMID:26049154 PMID:26183808 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases expression increases expression |
EXP |
triphenyl phosphate results in decreased expression of CYP1A1 protein triphenyl phosphate results in increased expression of CYP1A1 mRNA |
CTD |
PMID:30589522 PMID:30974155 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYP1A2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYP26B1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
multiple interactions increases expression |
ISO EXP |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CYP2B10 mRNA; [tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in increased expression of CYP2B10 mRNA triphenyl phosphate results in increased expression of CYP2B1 mRNA |
CTD |
PMID:29112739 PMID:30589522 PMID:32360330 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYP2F4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:82,416,108...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CYP2J4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp2t1 |
cytochrome P450, family 2, subfamily t, polypeptide 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYP2T1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:82,446,321...82,451,564
Ensembl chr 1:82,446,921...82,451,563
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CYP3A23-3A1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYP4A1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Cyp4a2 |
cytochrome P450, family 4, subfamily a, polypeptide 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYP4A2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:128,922,355...128,934,188
Ensembl chr 5:128,923,615...128,934,165
|
|
G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYP4A3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:129,097,571...129,115,488
Ensembl chr 5:129,097,926...129,115,463
|
|
G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CYP4A8 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:128,702,130...128,733,476
Ensembl chr 5:128,702,131...128,733,476
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CYP51 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CYP7A1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Dab1 |
DAB adaptor protein 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of DAB1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:118,392,953...119,513,625
Ensembl chr 5:119,140,533...119,510,552
|
|
G |
Dact2 |
dishevelled-binding antagonist of beta-catenin 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of DACT2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:55,181,023...55,191,026
Ensembl chr 1:55,181,024...55,191,096
|
|
G |
Dap |
death-associated protein |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DAP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:82,199,206...82,251,771
Ensembl chr 2:82,199,280...82,251,752
|
|
G |
Dapk1 |
death associated protein kinase 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of DAPK1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Dbp |
D-box binding PAR bZIP transcription factor |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DBP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745
|
|
G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DDAH1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:234,667,499...234,800,322
Ensembl chr 2:234,667,491...234,799,339
|
|
G |
Ddc |
dopa decarboxylase |
multiple interactions |
EXP |
[triphenyl phosphate co-treated with Flame Retardants] results in decreased expression of DDC mRNA |
CTD |
PMID:32243540 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of DDIT3 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DDIT4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddit4l |
DNA-damage-inducible transcript 4-like |
affects expression |
EXP |
triphenyl phosphate affects the expression of DDIT4L mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375
|
|
G |
Ddx21 |
DExD-box helicase 21 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of DDX21 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:30,534,319...30,554,513
Ensembl chr20:30,534,319...30,554,543
|
|
G |
Ddx6 |
DEAD-box helicase 6 |
affects expression |
EXP |
triphenyl phosphate affects the expression of DDX6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:44,931,127...44,967,773
Ensembl chr 8:44,931,974...44,964,405
|
|
G |
Dedd |
death effector domain-containing |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of DEDD mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:83,755,874...83,769,982
Ensembl chr13:83,756,108...83,769,332
|
|
G |
Dennd2a |
DENN domain containing 2A |
affects expression |
EXP |
triphenyl phosphate affects the expression of DENND2A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:68,233,016...68,332,235
Ensembl chr 4:68,233,958...68,332,105
|
|
G |
Depp1 |
DEPP autophagy regulator 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of DEPP1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
|
|
G |
Desi2 |
desumoylating isopeptidase 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DESI2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:89,961,767...90,011,255
Ensembl chr13:89,961,934...90,016,416
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
increases expression multiple interactions |
ISO |
triphenyl phosphate results in increased expression of DGAT2 mRNA [tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] affects the expression of DGAT2 mRNA |
CTD |
PMID:30966736 PMID:32360330 |
|
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
|
|
G |
Dgkd |
diacylglycerol kinase, delta |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DGKD mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:88,516,686...88,607,349
Ensembl chr 9:88,516,715...88,607,345
|
|
G |
Dido1 |
death inducer-obliterator 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DIDO1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:167,772,535...167,825,894
Ensembl chr 3:167,772,770...167,817,218
|
|
G |
Dipk1a |
divergent protein kinase domain 1A |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FAM69A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:1,772,412...1,843,508
Ensembl chr14:1,772,422...1,843,743
|
|
G |
Dipk2a |
divergent protein kinase domain 2A |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of DIPK2A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:95,070,695...95,089,815
Ensembl chr 8:95,030,279...95,089,815
|
|
G |
Dlg3 |
discs large MAGUK scaffold protein 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DLG3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr X:65,859,653...65,911,887
Ensembl chr X:65,860,172...65,910,322
|
|
G |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of DNAJB6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:5,452,683...5,556,679
Ensembl chr 4:5,452,683...5,556,659
|
|
G |
Dsc2 |
desmocollin 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DSC2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
|
|
G |
Dut |
deoxyuridine triphosphatase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DUT mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
|
|
G |
Dym |
dymeclin |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DYM mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:68,605,131...68,900,905
Ensembl chr18:68,605,185...68,900,903
|
|
G |
Echdc3 |
enoyl CoA hydratase domain containing 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ECHDC3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:72,070,697...72,093,519
Ensembl chr17:72,070,668...72,093,516
|
|
G |
Ecm1 |
extracellular matrix protein 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ECM1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671
|
|
G |
Edem2 |
ER degradation enhancing alpha-mannosidase like protein 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of EDEM2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:144,201,604...144,227,423
Ensembl chr 3:144,201,605...144,227,485
|
|
G |
Eef2k |
eukaryotic elongation factor-2 kinase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of EEF2K mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:175,393,119...175,454,452
Ensembl chr 1:175,393,154...175,455,164
|
|
G |
Efna1 |
ephrin A1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of EFNA1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:174,681,676...174,690,306
Ensembl chr 2:174,681,682...174,690,866
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of EGFR mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of EGLN1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:52,867,914...52,907,169
Ensembl chr19:52,869,486...52,907,777
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of EGLN3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Egr1 |
early growth response 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of EGR1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:26,463,333...26,465,531
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eif1a |
eukaryotic translation initiation factor 1A |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of EIF1A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:39,325,695...39,338,043
Ensembl chr18:39,325,202...39,338,696
|
|
G |
Eif4ebp3 |
eukaryotic translation initiation factor 4E binding protein 3 |
affects expression |
EXP |
triphenyl phosphate affects the expression of EIF4EBP3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:28,263,089...28,268,033
Ensembl chr18:28,162,311...28,268,024
|
|
G |
Elovl3 |
ELOVL fatty acid elongase 3 |
multiple interactions |
ISO |
[triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ELOVL3 mRNA |
CTD |
PMID:34323617 |
|
NCBI chr 1:244,997,287...245,001,115
Ensembl chr 1:244,997,287...245,001,115
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ELOVL6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
|
|
G |
Eml4 |
EMAP like 4 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of EML4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:11,219,545...11,334,824
Ensembl chr 6:11,219,566...11,334,879
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ENC1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
|
|
G |
Entr1 |
endosome associated trafficking regulator 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ENTR1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:9,200,967...9,207,688
Ensembl chr 3:9,200,967...9,207,688
|
|
G |
Epb41l1 |
erythrocyte membrane protein band 4.1-like 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of EPB41L1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:144,929,195...145,052,723
Ensembl chr 3:144,984,640...145,052,721
|
|
G |
Epcam |
epithelial cell adhesion molecule |
increases expression |
EXP |
triphenyl phosphate results in increased expression of EPCAM mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
|
|
G |
Epha2 |
Eph receptor A2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of EPHA2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of EPHX1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:92,714,315...92,744,124
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Eprs1 |
glutamyl-prolyl-tRNA synthetase 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of EPRS mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
|
|
G |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of EPS15 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:124,045,865...124,146,221
Ensembl chr 5:124,045,926...124,146,221
|
|
G |
Erg28 |
ergosterol biosynthesis 28 homolog |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ERG28 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:105,474,112...105,483,078
Ensembl chr 6:105,474,113...105,483,078
|
|
G |
Eri2 |
ERI1 exoribonuclease family member 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ERI2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:174,140,831...174,168,757
Ensembl chr 1:174,141,993...174,168,665
|
|
G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ERRFI1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:161,323,998...161,337,282
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions increases activity |
ISO |
triphenyl phosphate binds to and results in increased activity of ESR1 protein triphenyl phosphate metabolite results in increased activity of ESR1 protein; triphenyl phosphate results in increased activity of ESR1 protein [tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of ESR1 mRNA; [tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in increased expression of ESR1 mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of and results in decreased secretion of INS1 protein]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of and results in decreased secretion of LEP protein]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of CARTPT mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of CD36 mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of CYP4A10 mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of GHSR mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of NPY mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of NR0B2 mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1G mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1H mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1I mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of GHSR mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of INSR mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of KCNQ2 mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of KCNQ3 mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of KCNQ5 mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of KISS1 mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of LEPR mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of TRPC5 mRNA]; ESR1 gene mutant form results in decreased susceptibility to [tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] |
CTD |
PMID:23398518 PMID:24051214 PMID:24844797 PMID:26778350 PMID:28728110 PMID:29112739 PMID:32360330 PMID:33049310 More...
|
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
increases activity multiple interactions |
ISO |
triphenyl phosphate metabolite results in increased activity of ESR2 protein; triphenyl phosphate results in increased activity of ESR2 protein triphenyl phosphate metabolite inhibits the reaction [Estradiol results in increased activity of ESR2 protein] |
CTD |
PMID:26778350 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Etv6 |
ETS variant transcription factor 6 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ETV6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:166,849,031...167,085,211
Ensembl chr 4:166,847,686...167,084,992
|
|
G |
Evi2b |
ecotropic viral integration site 2B |
affects expression |
EXP |
triphenyl phosphate affects the expression of EVI2B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:64,472,693...64,474,311
Ensembl chr10:64,471,505...64,481,560
|
|
G |
Exph5 |
exophilin 5 |
affects expression |
EXP |
triphenyl phosphate affects the expression of EXPH5 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:53,698,825...53,775,371
Ensembl chr 8:53,698,852...53,773,169
|
|
G |
F11r |
F11 receptor |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of F11R mRNA |
CTD |
PMID:35752650 |
|
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
multiple interactions increases expression |
ISO |
[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mRNA; [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA 2-chloro-5-nitrobenzanilide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of FABP4 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mRNA]; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of FABP4 mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of FABP4 protein; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of FABP4 protein triphenyl phosphate results in increased expression of FABP4 mRNA; triphenyl phosphate results in increased expression of FABP4 protein |
CTD |
PMID:25062436 PMID:28437481 PMID:28934090 PMID:34323617 |
|
NCBI chr 2:91,580,858...91,585,578
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fabp5 |
fatty acid binding protein 5 |
increases expression decreases expression |
ISO EXP |
triphenyl phosphate results in increased expression of FABP5 mRNA triphenyl phosphate results in decreased expression of FABP5 mRNA |
CTD |
PMID:28934090 PMID:30589522 |
|
NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773
|
|
G |
Fabp7 |
fatty acid binding protein 7 |
affects expression |
EXP |
triphenyl phosphate affects the expression of FABP7 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
|
|
G |
Fam117a |
family with sequence similarity 117, member A |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FAM117A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:80,281,408...80,325,343
Ensembl chr10:80,281,408...80,325,343
|
|
G |
Fam117b |
family with sequence similarity 117, member B |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FAM117B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:61,340,291...61,418,531
Ensembl chr 9:61,340,249...61,408,483
|
|
G |
FAM120C |
family with sequence similarity 120C |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FAM120C mRNA |
CTD |
PMID:30589522 |
|
NCBI chr X:20,324,046...20,477,831
Ensembl chr X:20,323,381...20,477,275
|
|
G |
Fam168a |
family with sequence similarity 168, member A |
affects expression |
EXP |
triphenyl phosphate affects the expression of FAM168A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:155,057,352...155,203,439
Ensembl chr 1:155,057,352...155,201,220
|
|
G |
Fam174c |
family with sequence similarity 174 member C |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FAM174C mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:9,531,995...9,533,705
|
|
G |
Fam20c |
FAM20C, golgi associated secretory pathway kinase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FAM20C mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:15,826,864...15,885,423
Ensembl chr12:15,826,871...15,884,543
|
|
G |
Fam76a |
family with sequence similarity 76, member A |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FAM76A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:145,107,491...145,135,734
Ensembl chr 5:145,107,491...145,135,574
|
|
G |
Fam89a |
family with sequence similarity 89, member A |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of FAM89A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:52,710,003...52,722,591
Ensembl chr19:52,710,019...52,722,631
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FAS mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fasn |
fatty acid synthase |
increases expression multiple interactions affects expression |
ISO EXP |
triphenyl phosphate results in increased expression of FASN mRNA [tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in decreased expression of FASN mRNA triphenyl phosphate affects the expression of FASN mRNA |
CTD |
PMID:28163246 PMID:28934090 PMID:30589522 PMID:32360330 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbn1 |
fibrillin 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of FBN1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
|
|
G |
Fbxl22 |
F-box and leucine-rich repeat protein 22 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of FBXL22 mRNA |
CTD |
PMID:28934090 |
|
NCBI chr 8:67,069,998...67,076,685
Ensembl chr 8:67,069,998...67,076,685
|
|
G |
Fbxo30 |
F-box protein 30 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FBXO30 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:5,655,341...5,671,558
Ensembl chr 1:5,655,339...5,672,441
|
|
G |
Fbxo6 |
F-box protein 6 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of FBXO6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:158,576,729...158,582,520
Ensembl chr 5:158,576,759...158,582,525
|
|
G |
Fcer1g |
Fc epsilon receptor Ig |
affects expression |
EXP |
triphenyl phosphate affects the expression of FCER1G mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:83,649,447...83,654,215
Ensembl chr13:83,649,449...83,671,443
|
|
G |
Fcnb |
ficolin B |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of FCN1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:11,393,771...11,402,198
Ensembl chr 3:11,393,739...11,402,151
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FDFT1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of FGF21 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 1:96,083,495...96,084,738
Ensembl chr 1:96,083,441...96,090,454
|
|
|
|